Free cookie consent management tool by TermsFeed Policy Generator

Research groups

GC26 Clinical virology and zoonosis

The research group "Clinical Virology and Zoonoses" is a consolidated group of the IMIBIC whose research activity is part of IMIBIC’s Scientific Program "Infectious diseases, immunological and organ transplantation". Our main research lines include the study of diagnostic and therapeutic tools and the design of prevention strategies for viral and zoonotic diseases prevalent in our environment that pose a health risk to the population. The objectives of our research are the acquisition and translation of knowledge into health problem solutions and promotion of the concept of One Health. These objectives are achieved by implementing collaborative, multidisciplinary research activities to solve health problems common to animals and humans.

The group successfully develops various lines of research in the field of HIV infection as well as co-infection with HIV / HCV. Our efforts in this area are demonstrated by more than 80 publications in international journals with a high impact factor that has generated an accumulated impact factor of over 350 points and two innovation patents registered in the last five years. In the context of zoonotic diseases, more than fifteen articles have been published, accumulating an impact factor of more than 50 points in only 5 years.

Our group is also part of the AIDS Research Network (RIS, RD16 / 0025/0034) formed by numerous groups in Spain consolidated in HIV research.

Lines of Research

Our line of research on HIV infection includes studies aimed at the optimization of ART, pharmacokinetics, pharmacogenetics, the impact of the viral reservoir, AIDS and non-AIDS events related to HIV infection, fatty liver disease in the HIV-infected patient, as well as studies evaluating innate immunity against the virus.

The group successfully develops several lines of research in the field of HIV infection. Its work in this line is reflected by more than eighty publications in international journals with a high impact factor, which has generated a cumulative impact factor of more than 350 points and two innovation patents registered in the last five years.

 

The work carried out in this line of research has positioned the group as an international reference in the field of infection by the Hepatitis E virus. Proof of this is the publication of twenty-five articles in the last five years, having exceeded 100 impact factor points. Many of these papers are references in the drafting of national and international clinical practice guidelines.

This is the group's most recent line of research. In order to develop it collaborative and transversal research projects have been planned, involving national and international research groups from  different disciplines (medical, veterinary, environmental, food, etc.)  to tackle health problems in line with the One Health concept.

This line includes prospective studies of the prevalence of hepatitis E virus infection in patients in different clinical situations (acute hepatitis, fever of intermediate duration, HIV infection, pregnancy and so on), longitudinal studies to assess the prevalence of HEV infection among blood donors, evaluations of the prevalence of HEV infection in farm and game species, identification of sources of HEV infection of animal origin in our environment, as well as the identification of animal reservoirs of various pathogens.

Networks

    RIS - AIDS Research Network

    HEVnet - ECDC: NP/2016/OCS/7892/01

    CIBER - Enfermedades Infecciosas (CIBERINFEC). CB21/13/00083

Key Words

  • HIV
  • HCV
  • HEV
  • infection
  • AIDS
  • ART
  • CD4
  • hepatitis
  • pathogens
  • fibrosis
  • cirrhosis
  • innate immunity
  • pharmacogenomics
  • viral reservoir
  • zoonoses

Información Adicional

Recent publications

Caballero-Gomez J, Jimenez-Ruiz S, Lopez-Lopez P, Vicente J, Risalde MA, Cano-Terriza D, Frias M, Barasona JA, Rivero A, Garcia-Bocanegra I, Rivero-Juarez A; Emergent subtype of hepatitis E virus genotype 3 in wild boar in Spain. TRANSBOUNDARY AND EMERGING DISEASES. 2019 Sep;66(5):1803-1808. doi: 10.1111/tbed.13251. IF: 3,554. D1

Caballero-Gomez J, Rivero-Juarez A, Cano-Terriza D, Risalde MA, Lopez-Lopez P, Frias M, Jimenez-Ruiz S, Rivero A, Garcia-Bocanegra I; Survey for Hepatitis E virus infection in non-human primates in zoos in Spain. TRANSBOUNDARY AND EMERGING DISEASES. 2019 Jul;66(4):1771-1775. doi: 10.1111/tbed.13196. IF: 3,504. D1  

Rivero-Juarez A, Lopez-Lopez P, Frias M, Rivero A; Hepatitis E Infection in HIV-Infected Patients. FRONTIERS IN MICROBIOLOGY. 2019 Jun 26;10:1425. doi: 10.3389/fmicb.2019.01425. IF: 4,259. Q1.

Lopez-Lopez P, Rivero-Juarez A, Frias M, Machuca I, Caballero-Gomez J, Olivas I, Camacho A, Risalde MD, Garcia-Bocanegra I, Rivero A; Mutations in the Progesterone Receptor (PROGINS) May Reduce the Symptoms of Acute Hepatitis E and Protect Against Infection. FRONTIERS IN MICROBIOLOGY. 2019 Nov 7;10:2617. doi: 10.3389/fmicb.2019.02617. IF: 4,259. D2 Q1.  

Rivero-Juarez A, Jarilla-Fernandez M, Frias M, Madrigal-Sanchez E, Lopez-Lopez P, Andujar-Troncoso G, Machuca I, Camacho A, Munoz-Valbuena P, Rivero A; Hepatitis E virus in Spanish donors and the necessity for screening. JOURNAL OF VIRAL HEPATITIS. 2019 May;26(5):603-608. doi: 10.1111/jvh.13064. IF: 4,016. Q1. 

Frias M, Rivero-Juarez A, Tellez F, Palacios R, Jimenez-Arranz A, Pineda JA, Merino D, Gomez-Vidal MA, Perez-Camacho I, Camacho A, Rivero A; Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR. SCIENTIFIC REPORTS. 2019 Aug 29;9(1):12507. doi: 10.1038/s41598-019-48966-9. IF: 4,011. Q1

Lopez-Lopez P, Frias M, Camacho A, Rivero A, Rivero-Juarez A; Human Immunodeficiency Virus Infected Patients are Not at Higher Risk for Hepatitis E Virus Infection: A Systematic Review and Meta-Analysis. MICROORGANISMS. 2019 Nov 26;7(12). pii: E618. doi: 10.3390/microorganisms7120618. IF: 4,167. Q2   

Rivero-Juarez A, Tellez F, Castano-Carracedo M, Merino D, Espinosa N, Santos J, Macias J, Paniagua-Garcia M, Zapata-Lopez A, Collado A, Gomez-Vidal MA, Perez-Stachowski J, Munoz-Medina L, Fernandez-Fuertes E, Rivero A; Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients. HIV MEDICINE. 2019 Jul;20(6):359-367. doi: 10.1111/hiv.12715. IF: 3,734. Q2

Dr. Antonio Rivero Román
Dr. Antonio Rivero Román

Principal Investigator

Dr Antonio Rivero Juárez
Dr Antonio Rivero Juárez

Co-Principal Investigator

Projects

PROJECTS IN 2026

Activos

Non-EU international

ANTONIO RIVERO JUAREZ. ESGHV-RHEV Study - Evaluation of Rocahepevirus ratti infection as emerging cause of acute hepatitis of unknown origin in Europe. Entidad Financiadora: EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. Código: ESCMID-2023-01

National

ANTONIO RIVERO JUAREZ. Evaluación clínica y experimental del impacto en el sistema nervioso central del ratVHE. Entidad Financiadora: INSTITUTO DE SALUD CARLOS III. Código: PI25/01003

PEDRO LOPEZ LOPEZ. Secuenciación completa de VHE mediante el uso de tecnología Nanopore en la cohorte GEHEP-014. Entidad Financiadora: SOCIEDAD ESPAÑOLA DE ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. Código: GEHEP24/01

Regional

MOISÉS GONZÁLVEZ JUAN. Proyectos No Competitivos - Antonio Rivero Juárez. Entidad Financiadora: CONSEJERÍA DE SANIDAD, PRESIDENCIA Y EMERGENCIAS. Código: EXC-2024-02

 

PROJECTS IN 2025

Activos

Internacional no UE

ANTONIO RIVERO JUAREZ. ESGHV-RHEV Study - Evaluation of Rocahepevirus ratti infection as emerging cause of acute hepatitis of unknown origin in Europe. Entidad Financiadora: EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. Código: ESCMID-2023-01

ANTONIO RIVERO ROMAN. Real-life effectiveness of BIC/FTC/TAF in naïve patients with CD4+ less than 200 cells/mL or AIDS events. Entidad Financiadora: GILEAD SCIENCES EUROPE LTD.. Código: Gilead-ISR-2021-01

Nacional

ANTONIO RIVERO JUAREZ. Evaluación clínica y experimental del impacto en el sistema nervioso central del ratVHE. Entidad Financiadora: INSTITUTO DE SALUD CARLOS III. Código: PI25/01003

Regional

ANTONIO RIVERO JUAREZ. Proyectos No Competitivos - Antonio Rivero Juárez. Entidad Financiadora: CONSEJERÍA DE SANIDAD, PRESIDENCIA Y EMERGENCIAS. Código: EXC-2024-02

MARIA DE LOS ANGELES RISALDE MOYA. Proyectos No Competitivos - Mª Ángeles Risalde Moya. Entidad Financiadora: CONSEJERÍA DE SANIDAD, PRESIDENCIA Y EMERGENCIAS. Código: EXC-2024-03

 

PROJECTS IN 2024

Activos

Internacional no UE

ANTONIO RIVERO JUAREZ. ESGHV-RHEV Study - Evaluation of Rocahepevirus ratti infection as emerging cause of acute hepatitis of unknown origin in Europe. Entidad Financiadora: EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. Código: ESCMID-2023-01

ANTONIO RIVERO ROMAN. Real-life effectiveness of BIC/FTC/TAF in naïve patients with CD4+ less than 200 cells/mL or AIDS events. Entidad Financiadora: GILEAD SCIENCES EUROPE LTD.. Código: Gilead-ISR-2021-01

NACIONAL

ANTONIO RIVERO JUAREZ. Magnitud e impacto clínico de la infección por Orthohepevirus C. Entidad Financiadora: INSTITUTO DE SALUD CARLOS III. Código: PI22/01098

ANTONIO RIVERO ROMAN. Evaluación de la infección por Orthohepevirus C como causa emergente de enfermedad de origen zoonótico. Entidad Financiadora: INSTITUTO DE SALUD CARLOS III. Código: PI21/00793

REGIONAL

ANTONIO RIVERO JUAREZ. Proyectos No Competitivos - Antonio Rivero Juárez. Entidad Financiadora: CONSEJERÍA DE SALUD Y CONSUMO. Código: EXC-2024-02

IGNACIO GARCIA BOCANEGRA. Proyectos No Competitivos - Mª Ángeles Risalde Moya. Entidad Financiadora: CONSEJERÍA DE SALUD Y CONSUMO. Código: EXC-2024-03

 

PROJECTS IN 2023

Ongoing projects

National

ANTONIO RIVERO JUAREZ. Magnitud e impacto clínico de la infección por Orthohepevirus C. Funding Agency: INSTITUTO DE SALUD CARLOS III. Reference: PI22/01098

ANTONIO RIVERO ROMAN. Evaluación de la infección por Orthohepevirus C como causa emergente de enfermedad de origen zoonótico. Funding Agency: INSTITUTO DE SALUD CARLOS III. Reference: PI21/00793

International

ANTONIO RIVERO ROMAN. Real-life effectiveness of BIC/FTC/TAF in naïve patients with CD4+ less than 200 cells/mL or AIDS events. Funding Agency: GILEAD SCIENCES EUROPE LTD.. Reference: Gilead-ISR-2021-01

ANTONIO RIVERO JUÁREZ. Evaluation of Rocahepevirus ratti infection as emerging cause of acute hepatitis of unknown origin in Europe (ESGHV-RHEV Study). Funding Agency: European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Reference:  ESCMID-2023-01.

PROJECTS IN 2022

Ongoing projects

Regional

MARIA DE LOS ANGELES RISALDE MOYA; Infectividad del virus de la Hepatitis E detectado en alimentos de origen porcino utilizando modelos animales y cultivos celulares. (Estudio HepEfood) Funding Agency: CONSEJERÍA DE SALUD Y CONSUMO; Reference: 116190130287

National

ANTONIO RIVERO JUAREZ; ACTUALIZACIÓN EN EL DIAGNÓSTICO, MANEJO, TRATAMIENTO Y PREVENCIÓN DE LAS HEPATITIS VIRALES Funding Agency: GILEAD SCIENCES EUROPE LTD.; Reference: GLD20_0014

ANTONIO RIVERO ROMAN; EVALUACIÓN DE LA INFLUENCIA DE LA ENFERMEDAD HEPÁTICA GRASA NO ALCOHÓLICA SOBRE EVENTOS CLÍNICOS Y MORTALIDAD DE LOS PACIENTES INFECTADOS POR VIH Funding Agency: INSTITUTO DE SALUD CARLOS III; Reference: PI18/01270

ANTONIO RIVERO JUAREZ; Trazabilidad epidemiológica y microbiológica de la infección por el virus de la Hepatitis E: Estudio TrazHE Funding Agency: INSTITUTO DE SALUD CARLOS III; Reference: PI19/00864

ANTONIO RIVERO ROMAN; Evaluación de la infección por Orthohepevirus C como causa emergente de enfermedad de origen zoonótico Funding Agency: INSTITUTO DE SALUD CARLOS III; Reference: PI21/00793

International

ANTONIO RIVERO ROMAN; Real-life effectiveness of BIC/FTC/TAF in naïve patients with CD4+ less than 200 cells/mL or AIDS events Funding Agency: GILEAD SCIENCES EUROPE LTD.; Reference: Gilead-ISR-2021-01

Publications

Publications in 2025

Lopez C, Sanchez-Sanchez R, Corona D, Perez AB, Bravo F, de Alba M, Bracero A, Cazorla C, Vázquez A, Sánchez-Seco MP, Negredo A, Gómez-Pinedo U, Martinez-Martinez L, Torre-Cisneros J, de la Fuente C. A Fatal Case of Monkeypox-Associated Encephalitis in a Non-HIV-Infected Patient. CRITICAL CARE EXPLORATIONS. 2025. -. DOI:10.1097/CCE.0000000000001272. IF: 2,7          Q2     D5

Frías M, Chicano-Gálvez E, Rivero-Juárez A, Gordon A, Corona-Mata D, Moyano JM, Peralbo-Molina A, Camacho A, Pérez-Valero I, Malagón MD, Rivero A. Afamin and Apolipoprotein F Associated With Liver Steatosis From People Living With HIV: A Discovery Study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2025. 1767-1774. DOI:10.1111/apt.70119. IF: 6,7          Q1     D1

Santos-Silva S, López-López P, Pérez AB, Freyre-Carrillo C, Fuentes A, Rivero-Juárez A, van der Poel WHM, Mesquita JR, Gonçalves HMR. Development and clinical evaluation of a nanoparticle-based biosensor for rapid detection of Hepatitis E virus in human serum. ANALYTICA CHIMICA ACTA. 2025. -. DOI:10.1016/j.aca.2025.344758. IF: 6          Q1     D2

Barbero-Moyano J, Gonzálvez M, Bravo-Barriga D, García-Bocanegra I, López-López P, Rivero-Juárez A, Ruiz-Fons F, Moreno I, Carpio AJ, Martínez R, Pérez AB, Jimenez MA, Rivero A, Risalde MA. Epidemiological landscape in a Mediterranean hotspot of human leishmaniosis in Spain under a One Health approach. PATHOGENS AND GLOBAL HEALTH. 2025. 122-133. DOI:10.1080/20477724.2025.2480083. IF: 2,5          Q2     D3

Corma-Gómez A, Corona-Mata D, Martín-Carmona J, Galindo MJ, Camacho A, Martín-Sierra C, Gallo-Marín M, Rincón P, Perez-Valero I, Pérez-García M, Carrasco-Dorado A, Pineda JA, Rivero-Juárez A, Rivero A, Real LM, Macías J. FibroScan-AST Score vs Liver Stiffness for the Prediction of Liver Events After HCV Cure. OPEN FORUM INFECTIOUS DISEASES. 2025. -. DOI:10.1093/ofid/ofae628. IF: 3,8          Q1     D3

Caballero-Gómez J, Fajardo-Alonso T, Rios-Muñoz L, Beato-Benítez A, Casares-Jiménez M, García-Bocanegra I, Cuadrado-Matías R, Martí-Marco A, Martínez J, Martínez R, Nevado EM, Ruiz-Fons F, Mesquita JR, Fuentes M, Corona-Mata D, Gonzálvez M, Lizana V, Soriano P, Foronda P, Crailsheim D, Rivero-Juárez A, Rivero A. National survey of the rat hepatitis E virus in rodents in Spain, 2022 to 2023. EUROSURVEILLANCE. 2025. -. DOI:10.2807/1560-7917.ES.2025.30.12.2400473. IF: 7,8          Q1     D1

Caballero-Gómez J, Fajardo-Alonso T, Rios-Muñoz L, Cuadrado-Matías R, Somoano A, Panadero R, Casares-Jiménez M, García-Bocanegra I, Ruiz L, Beato-Benítez A, Ruiz-Fons F, Jiménez-Martín D, Espí A, del Cerro A, Martínez R, Frías M, Rivero-Juárez A, Rivero A. Occurrence and genetic diversity of the zoonotic rat hepatitis E virus in small mammal species, Spain. VETERINARY RESEARCH. 2025. -. DOI:10.1186/s13567-025-01492-1. IF: 3,5          Q1     D1

Caballero-Gómez J, Casares-Jimenez M, Gallo-Marín M, Pereira-Pardo S, Beato-Benítez A, Poyato A, Guerra R, Avellón A, Schilling-Loeffler K, Freyre-Carrillo C, García-Bocanegra I, Jiménez-Martin D, Corona-Mata D, Viciana I, Fajardo T, Muñoz-Chimeno M, Quevedo MA, Rios-Muñoz L, Pérez AB, Cano-Terriza D, Macías J, Fuentes A, Johne R, Rivero-Juarez A, Rivero A. Rat hepatitis E virus as an aetiological agent of acute hepatitis of unknown origin. JOURNAL OF HEPATOLOGY. 2025. 662-669. DOI:10.1016/j.jhep.2025.02.027; 10.1016/j.jhep.2025.02.027. IF: 33          Q1     D1

Pérez-Valero I, Mata DC, Espejo AC, Gallo M, de Morales AGGR, Fanciulli C, Martín-Carbonero L, Isbert SC, Gutiérrez CH, Asensi V, Juarez AR, Rivero A. Real-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With Human Immunodeficiency Virus Starting Therapy With AIDS-Defining Conditions: Results From the CoRIS Cohort-The ACTUAS II Study. CLINICAL INFECTIOUS DISEASES. 2025. e93-e101. DOI:10.1093/cid/ciaf162. IF: 7,3          Q1     D1

Caballero-Gómez J, García-Bocanegra I, Cano-Terriza D, Casares-Jiménez M, Jiménez-Ruiz S, Risalde MA, Ríos-Muñoz L, Rivero-Juárez A, Rivero A. Zoonotic rat hepatitis E virus infection in pigs: farm prevalence and public health relevance. PORCINE HEALTH MANAGEMENT. 2025. -. DOI:10.1186/s40813-025-00450-9. IF: 3,1          Q1     D1

Santos-Silva S, Palmeira JD, Ferreira H, Romalde JL, Gonçalves HMR, Van der Poel WHM, Nascimento MSJ, Rivero-Juarez A, Mesquita JR. Absence of hepatitis E virus RNA in bovines from Portugal. VETERINARY RESEARCH COMMUNICATIONS. 2025. -. DOI:10.1007/s11259-025-10839-0. IF: 2          Q2     D3

Cano-Terriza D, Fernández-Bastit L, Vergara-Alert J, Váquez-Calero DB, Castro-Scholten S, Caballero-Gómez J, García-Bocanegra I, Segalés J. Assessment of SARS-CoV-2 exposure in exotic pets in Spain. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES. 2025. -. DOI:10.1016/j.cimid.2024.102289. IF: 2          Q2     D3

Figueiredo AM, Dashti A, Maloney JG, Molokin A, George NS, Köster PC, Bailo B, de las Matas AS, Habela MA, Rivero-Juarez A, Vicente J, Serrano E, Arnal MC, de Luco DF, Morrondo P, Armenteros JA, Balseiro A, Cardona GA, Martínez-Carrasco C, Torres RT, Fonseca C, Mysterud A, Carvalho J, Calero-Bernal R, González-Barrio D, Santín M, Carmena D. Blastocystis in free-ranging wild ruminant species across the Iberian Peninsula. VETERINARY RESEARCH. 2025. -. DOI:10.1186/s13567-025-01563-3. IF: 3,5          Q1     D1

Caballero-Gómez J, Avalos G, Matas-Méndez P, Figueiredo AM, Castro-Scholten S, Jiménez-Martín D, Köster PC, Santín M, Bailo B, Cano-Terriza D, Sarmento P, Neves N, Carrapato C, González-Barrio D, Mateo M, García-Bocanegra I, Dashti A, Sánchez S, Carmena D. Dietary profiles of wild carnivores and Blastocystis occurrence: The case of the endangered Iberian lynx (Lynx pardinus) and systematic review. RESEARCH IN VETERINARY SCIENCE. 2025. -. DOI:10.1016/j.rvsc.2024.105518. IF: 1,8          Q2     D4

Diakoudi G, Castro-Scholten S, Caballero-Gómez J, Di Martino B, Di Profio F, Sarchese V, Pellegrini F, Lanave G, Decaro N, García-Bocanegra I, Martella V. Domestic Cat Hepadnavirus Infection in Iberian Lynxes. EMERGING INFECTIOUS DISEASES. 2025. 160-163. DOI:10.3201/eid3101.240568. IF: 6,6          Q1     D1

Caballero-Gómez J, Casais R, Castro-Scholten S, Iglesias N, Oleaga A, Fernández-Verón I, López-López G, Mata E, Nájera F, Paniagua J, Salcedo J, Montoya-Oliver JI, García-Bocanegra I. Endemic and widespread exposure to Sarcoptes scabiei in the threatened Iberian lynx (Lynx pardinus). PREVENTIVE VETERINARY MEDICINE. 2025. -. DOI:10.1016/j.prevetmed.2025.106585. IF: 2,4          Q1     D2

Santos-Silva S, Lois M, Machado A, Bordalo A, Cruz AVS, Gonçalves HMR, van der Poel WHM, Nascimento MSJ, Rivero-Juarez A, Romalde JL, Mesquita JR. Environmental Surveillance of Hepatitis E Virus and Rat Hepatitis E Virus in Portugal and Spain, 2020-2022. JOURNAL OF MEDICAL VIROLOGY. 2025. -. DOI:10.1002/jmv.70414. IF: 4,6          Q1     D2

Sánchez-Sánchez M, Caballero-Gómez J, Contreras M, Moraga-Fernández A, Munoz-Hernández C, Fernández-Verón I, Fischer K, Bost C, Castro-Scholten S, Baz-Flores S, del Rey T, Nájerah F, Montoya-Oliveri I, Salcedoj J, de Meraa IGF, Garcia-Bocanegra I. Epidemiological surveillance of Crimean-Congo haemorrhagic fever virus in the Iberian lynx (Lynx pardinus), 2010-2022. VETERINARY MICROBIOLOGY. 2025. -. DOI:10.1016/j.vetmic.2025.110722. IF: 2,7          Q1     D2

Jiménez-Martín D, Muñoz-Fernández L, Agulló-Ros I, Jiménez-Pizarro N, Cano-Terriza D, García-Bocanegra I, Romero B, Caballero-Gómez J, Gonzálvez M, Rejón S, Martínez R, Risalde MA. Evaluation of techniques for post-mortem diagnosis of Mycobacterium tuberculosis complex infection in goats. VETERINARY MICROBIOLOGY. 2025. -. DOI:10.1016/j.vetmic.2025.110485. IF: 2,7          Q1     D2

Castro-Scholten S, Caballero-Gómez J, Bravo-Barriga D, Llorente F, Cano-Terriza D, Jiménez-Clavero MA, Jiménez-Martín D, Camacho-Sillero L, García-Bocanegra I. Exposure to West Nile Virus in Wild Lagomorphs in Spanish Mediterranean Ecosystems. ZOONOSES AND PUBLIC HEALTH. 2025. 207-214. DOI:10.1111/zph.13200. IF: 2,3          Q1     D2

Pereira S, Pérez-Rivilla A, Carracedo R, Lopez-Lopez P, Rodriguez-Iglesias M, Benito R, Fuentes A, Lopez-Ruz MA, Freyre-Carrillo C, Odero MD, Parajo N, Garcia F, Rivero-Juarez A, Aguilera ARJA, Aguilera A. Hepatitis E virus screening in solid organ transplant recipients: prevalence and implications for implementation, Spain, 2021 to 2023. EUROSURVEILLANCE. 2025. -. DOI:10.2807/1560-7917.ES.2025.30.44.2500254. IF: 7,8          Q1     D1

Martín-Carmona J, Corma-Gómez A, Moyano JM, Téllez F, Arenga-Barrios D, Serrano-Fuentes M, Vázquez ACM, Corona-Mata D, Lorite MNN, Vera-Méndez FJ, Barroso I, Palacios R, de los Santos I, Belinchón O, Galera C, Imaz A, Merino D, Reus-Bañuls SJ, Galindo MJ, López-Zuñiga MA, Pineda JA, Macías J. Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological response. ECLINICALMEDICINE. 2025. -. DOI:10.1016/j.eclinm.2025.103227. IF: 10          Q1     D1

Macias J, Frias M, Pineda JA, Corona-Mata D, Corma-Gomez A, Rivero-Juarez A, Santos M, Garcia-Deltoro M, Rivero A, Ricart-Olmos C, Gonzalez-Serna A, Real LM. Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2025. 550-557. DOI:10.1111/apt.18413. IF: 6,7          Q1     D1

Blanch J, Martinez E, Mena A, Duenas C, Bernal E, Cabello A, Hayek M, Mican R, Morillo-Verdugo R, Sainz M, Conde CG, Perez-Valero I. Impact of training healthcare professionals in the detection and management of neuropsychiatric comorbidities in people with HIV: The CONECTAR project in Spain. HIV MEDICINE. 2025. 721-733. DOI:10.1111/hiv.70002. IF: 3,2          Q2     D4

Izquierdo R, Vallejo A, Suárez-García I, Martín-Hondarza A, Gutierrez F, Perez-Molina JA, García DV, Macías J, Rivero A, Olalla J, Montero-Alonso M, Asensi V, Moreno S, Jarrín I, Rava M. Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2025. 274-282. DOI:10.1097/QAI.0000000000003667. IF: 2,2          Q3     D

Badillo-Viloria M, García-Bocanegra I, Jaramillo SD, Mattar S, Frías-Casas M, Cano-Terriza D. Molecular Characterization and Epidemiology of Anaplasmataceae in Ticks and Domestic Animals in the Colombian Caribbean. ANIMALS. 2025. -. DOI:10.3390/ani16010008. IF: 2,7          Q1     D2

Barbero-Moyano J, Caballero-Gómez J, Gonzálvez M, Martínez R, Moreno I, Berriatua E, Sánchez-Sánchez M, Paniagua J, Fernández-Veron I, del Rey-Wamba MT, Crespo E, Montoya-Oliver JI, Salcedo J, Risalde MA, García-Bocanegra I. Monitoring of Leishmania infantum exposure in the Iberian lynx (Lynx pardinus). PREVENTIVE VETERINARY MEDICINE. 2025. -. DOI:10.1016/j.prevetmed.2024.106366. IF: 2,4          Q1     D2

Martin-Carmona J, Corma-Gómez A, Téllez F, Arenga-Barrios D, Serrano-Fuentes M, Morano L, Corona-Mata D, Lorite MNN, Vera-Méndez FJ, Alados JC, Palacios R, de los Santos I, Geijo P, Imaz A, Merino D, Reus-Bañuls SJ, Galindo MJ, López-Ruz MA, Galera C, Pineda JA, Macías J. No Impact of HIV Coinfection on Mortality in Patients With Hepatitis C Virus Infection After Sustained Virological Response. CLINICAL INFECTIOUS DISEASES. 2025. 835-841. DOI:10.1093/cid/ciae473. IF: 7,3          Q1     D1

Yeh-Gorocica A, Rivero-Juárez A, Ayora-Talavera G, Suárez-Galaz A, Torres-Castro M. Search for Sarbecovirus in bats of Yucatan, southeastern Mexico. REVISTA DE INVESTIGACIONES VETERINARIAS DEL PERU. 2025. -. DOI:10.15381/rivep.v36i3.29363. IF: 0,2          Q4     D

Jiménez-Martín D, García-Bocanegra I, Jiménez-Ruiz S, Caballero-Gómez J, Castro-Scholten S, Paniagua J, Prieto-Yerro P, Cano-Terriza D. Seroepidemiological study of Chlamydia abortus in domestic and wild ruminants in Spanish Mediterranean ecosystems. PREVENTIVE VETERINARY MEDICINE. 2025. -. DOI:10.1016/j.prevetmed.2025.106600. IF: 2,4          Q1     D2

Hasanoglu I, Rivero-Juárez A, Sahin GÖ. When Metabolic Dysfunction-Associated Steatotic Liver Disease Meets Viral Hepatitis. JOURNAL OF CLINICAL MEDICINE. 2025. -. DOI:10.3390/jcm14103422. IF: 2,9          Q1     D2

Dudman S, Zerja A, Hasanoglu I, Ruta S, van Welzen B, Nicolini LA, Yonga P, Overbo J, Rawat S, Habibovic S, Kim TB, Rivero-Juarez A, ESGVH Members. Global vaccination against hepatitis E virus: position paper from the European Society of Clinical Microbiology and Infectious Diseases Viral Hepatitis Study Group. CLINICAL MICROBIOLOGY AND INFECTION. 2025. 201-210. DOI:10.1016/j.cmi.2024.11.016. IF: 8,5          Q1     D1

 

López-López P, Cruz AVS, Santos-Silva S, Rivero-Juárez A, Rebelo H, Mesquita JR. Molecular Survey of Protist Enteroparasites in Bats (Order Chiroptera) from Portugal. ACTA PARASITOLOGICA. 2025. -. DOI:10.1007/s11686-024-00985-x. IF: 1,5          Q2     D4

 

 

Publications in 2024

Caballero-Gómez J, Pereira S, Rivero-Calle I, Perez AB, Viciana I, Casares-Jiménez M, Rios-Muñoz L, Rivero-Juarez A, Aguilera A, Rivero A. Acute Hepatitis in Children Due to Rat Hepatitis E Virus. JOURNAL OF PEDIATRICS. 2024. DOI: 10.1016/j.jpeds.2024.114125. IF: 3,9      Q1  D1

Corona-Mata D, Rivero-Juárez A, Camacho A, Ruiz-Torres L, Ruiz-Cáceres I, Pérez AB, Darder BD, Cáceres-Anillo D, Castro-Granados MD, Lizaur-Barbudo M, Cabrera-Gisbert MV, Redondo-Écija J, Aparicio-Aparicio A, Manchado-López L, Cobos L, Pérez-Valero I, Rivero A. Comparison of hepatitis B and SARS-CoV2 vaccination rates in people who attended Drugs and Addiction Centres. FRONTIERS IN PUBLIC HEALTH. 2024. DOI: 10.3389/fpubh.2023.1258095. IF: 3      Q2  D3

Casares-Jimenez M, Garcia-Garcia T, Suárez-Cárdenas JM, Perez-Jimenez AB, Martín MA, Caballero-Gómez J, Michán C, Corona-Mata D, Risalde MA, Perez-Valero I, Guerra R, Garcia-Bocanegra I, Rivero A, Rivero-Juarez A, Garrido JJ. Correlation of hepatitis E and rat hepatitis E viruses urban wastewater monitoring and clinical cases. SCIENCE OF THE TOTAL ENVIRONMENT. 2024. DOI: 10.1016/j.scitotenv.2023.168203. IF: 8,2      Q1  D1

Corona D, Pérez-Valero I, Camacho A, Liarte AG, Montero-Alonso M, Alemán MR, Ruiz-Seco P, González AP, Riera M, Jarrin I, Rivero-Juárez A, Rivero A. Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2024. DOI: 10.1016/j.ijantimicag.2023.107016. IF: 4,9      Q1  D2

Castro-Scholten S, Caballero-Gómez J, Cano-Terriza D, Jiménez-Martín D, Rouco C, Beato-Benítez A, Camacho-Sillero L, García-Bocanegra I. Exposure to Coxiella burnetii in Wild Lagomorphs in Spanish Mediterranean Ecosystems. ANIMALS. 2024. DOI: 10.3390/ani14050749. IF: 2,7      Q1  D2

Gómez JC, Cano-Terriza D, Segalés J, Vergara-Alert J, Zorrilla I, del Rey T, Paniagua J, Gonzálvez M, Fernández-Bastit L, Nájera F, Montoya-Oliver JI, Salcedom J, García-Bocanegra I. Exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the endangered Iberian lynx (Lynx pardinus). VETERINARY MICROBIOLOGY. 2024. DOI: 10.1016/j.vetmic.2024.110001. IF: 2,4      Q1  D2

Santos-Silva S, Santos N, López-López P, Nascimento MSJ, Gonçalves HMR, Van der Poel WHM, Rivero-Juarez A, Mesquita JR. Hepatitis E virus in wild and domestic rabbits from Portugal: a combined molecular and longitudinal serological study. VETERINARY RESEARCH COMMUNICATIONS. 2024. 3283-3289. DOI: 10.1007/s11259-024-10452-7. IF: 1,8      Q2  D4

Serrano-Rísquez C, Omar M, Rallon N, Benito JM, Gómez-Vidal A, Marquez FJ, Aljan M, Rivero-Juárez A, Pérez-Valero I, Rivero A, Sinangil F, Saulle I, Biasin M, Clerici M, Forthal D, Saéz ME, Caruz A. Impact of Human Leukocyte Antigen Allele-Killer Cell Immunoglobulin-like Receptor Partners on Sexually Transmitted Human Immunodeficiency Virus Type 1 Infection. JOURNAL OF INFECTIOUS DISEASES. 2024. e1077-e1081. DOI: 10.1093/infdis/jiae436. IF: 5      Q1  D2

Fajardo-Alonso T, García-Bocanegra I, Risalde MA, Rivero-Juárez A, Jiménez-Ruiz S, Cano-Terriza D, Casares-Jiménez M, Laguna E, Acevedo P, Frías M, Vicente J, Rivero A, Caballero-Gómez J. Longitudinal survey of hepatitis E virus in extensively raised pigs in Spain. VETERINARY MICROBIOLOGY. 2024. DOI: 10.1016/j.vetmic.2024.110256. IF: 2,4      Q1  D2

Cruz AVS, López-López P, Santos-Silva S, Rivero-Juárez A, Rebelo H, Mesquita JR. Molecular detection of Enterocytozoon bieneusi in bats from Portugal. MEDICAL MYCOLOGY. 2024. DOI: 10.1093/mmy/myae019. IF: 2,7      Q2  D5

López-López P, Risalde MA, Casares-Jiménez M, Caballero-Gómez J, Martín-Gómez A, Martínez-Blasco J, Agulló-Ros I, Frías M, García-Bocanegra I, Gómez-Villamandos JC, Rivero A, Rivero-Juárez A. Prevalence of Paslahepevirus balayani in commercial swine food products from Spain. ONE HEALTH. 2024. DOI: 10.1016/j.onehlt.2024.100690. IF: 4,1      Q1  D2

Casares-Jimenez M, Rivero-Juarez A, Lopez-Lopez P, Montes ML, Navarro-Soler R, Peraire J, Espinosa N, Alemán-Valls MR, Garcia-Garcia T, Caballero-Gomez J, Corona-Mata D, Perez-Valero I, Ulrich RG, Rivero A. Rat hepatitis E virus (Rocahepevirus ratti) in people living with HIV. EMERGING MICROBES & INFECTIONS. 2024. DOI: 10.1080/22221751.2023.2295389. IF: 8,4      Q1  D1

Santos-Silva S, Romalde JL, Bento JT, Cruz AVS, López-López P, Goncalves HMR, van der Poel WHM, Nascimento MSJ, Rivero-Juarez A, Mesquita JR. Serological and Molecular Survey of Hepatitis E Virus in Small Ruminants from Central Portugal. FOOD AND ENVIRONMENTAL VIROLOGY. 2024. 516-524. DOI: 10.1007/s12560-024-09612-4. IF: 4,1      Q2  D3

Casares-Jimenez M, Corona-Mata D, Garcia-Garcia T, Manchado-Lopez L, Rios-Muñoz L, de Guia-Castro M, Lopez-Lopez P, Caceres-Anillo D, Camacho A, Caballero-Gomez J, Perez-Valero I, Gallo-Marin M, Perez AB, Ulrich RG, Rivero-Juarez A, Rivero A. Serological and molecular survey of rat hepatitis E virus (Rocahepevirus ratti) in drug users. EMERGING MICROBES & INFECTIONS. 2024. DOI: 10.1080/22221751.2024.2396865. IF: 8,4      Q1  D1

Frías M, Caballero-Gómez J, Vázquez A, Madrigal E, Ruiz-Fons F, Gallo M, Herrero L, Jarilla M, Garcia-Bocanegra I, Rivero-Juárez A, Rivero A. Serosurvey of Blood Donors to Assess West Nile Virus Exposure, South-Central Spain. EMERGING INFECTIOUS DISEASES. 2024. 1496-1498. DOI: 10.3201/eid3007.240450. IF: 7,2      Q1  D1

Martín-Sierra C, Bravo MJ, Sáez ME, De Rojas I, Santos M, Martín-Carmona J, Corma-Gómez A, González-Serna A, Royo JL, Pineda JA, Rivero A, Rivero-Juárez A, Macías J, Real LM. The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations (GEHEP-012 study). ANTIVIRAL RESEARCH. 2024. DOI: 10.1016/j.antiviral.2024.105795. IF: 4,5      Q1  D2

Castro-Scholten S, Caballero-Gómez J, Bost C, Cano-Terriza D, Jiménez-Martín D, Groschup MH, Frías M, Camacho-Sillero L, Fischer K, García-Bocanegra I. Absence of Crimean-Congo hemorrhagic fever virus in wild lagomorphs and their ticks in Spanish Mediterranean ecosystems. VETERINARY MICROBIOLOGY. 2024. DOI: 10.1016/j.vetmic.2024.110217. IF: 2,4      Q1  D2

Bost C, Castro-Scholten S, Sadeghi B, Cano-Terriza D, Frías M, Jiménez-Ruiz S, Groschup MH, García-Bocanegra I, Fischer K. Approaching the complexity of Crimean-Congo hemorrhagic fever virus serology: A study in swine. JOURNAL OF VIROLOGICAL METHODS. 2024. DOI: 10.1016/j.jviromet.2024.114915. IF: 2,2      Q3  D

Köster PC, Figueiredo AM, Maloney JG, Dashti A, Bailo B, Torres RT, Fonseca C, Mysterud A, Habela MA, Rivero-Juarez A, Vicente J, Serrano E, Arnal MC, de Luco DF, Armenteros JA, Balseiro A, Cardona GA, Carvalho J, Hipólito D, Fernandes J, Palmeira JD, Calero-Bernal R, González-Barrio D, Santin M, Carmena D. Blastocystis occurrence and subtype diversity in European wild boar (Sus scrofa) from the Iberian Peninsula. VETERINARY RESEARCH. 2024. DOI: 10.1186/s13567-024-01385-9. IF: 3,7      Q1  D1

Santos-Silva S, Moraes DFDD, López-López P, Paupério J, Queirós J, Rivero-Juarez A, Lux L, Ulrich RG, Gonçalves HMR, van der Poel WHM, Nascimento MSJ, Mesquita JR. Detection of hepatitis E virus genotype 3 in an Algerian mouse (Mus spretus) in Portugal. VETERINARY RESEARCH COMMUNICATIONS. 2024. 1803-1812. DOI: 10.1007/s11259-024-10293-4. IF: 1,8      Q2  D4

Frías M, Fischer K, Castro-Scholten S, Bost C, Cano-Terriza D, Risalde MA, Acevedo P, Jiménez-Ruiz S, Sadeghi B, Groschup MH, Caballero-Gómez J, Garcia-Bocanegra I. Epidemiologic Survey of Crimean-Congo Hemorrhagic Fever Virus in Suids, Spain. EMERGING INFECTIOUS DISEASES. 2024. 984-990. DOI: 10.3201/eid3005.240074. IF: 7,2      Q1  D1

Castro-Scholten S, García-Bocanegra I, Iglesias N, Casais R, Cano-Terriza D, Jiménez-Martín D, Barbero-Moyano J, Camacho-Sillero L, Rouco C, Caballero-Gómez J. Epidemiological survey and risk factors associated with Sarcoptes scabiei in wild lagomorphs in Spanish Mediterranean ecosystems. RESEARCH IN VETERINARY SCIENCE. 2024. DOI: 10.1016/j.rvsc.2024.105344. IF: 2,2      Q1  D2

Castro-Scholten S, García-Bocanegra I, Rejón-Segura S, Cano-Terriza D, Jiménez-Martín D, Rouco C, Camacho-Sillero L, Arenas A, Caballero-Gómez J. Francisella tularensis in Wild Lagomorphs in Southern Spain's Mediterranean Ecosystems. ANIMALS. 2024. DOI: 10.3390/ani14233376. IF: 2,7      Q1  D1

Mesquita JR, Santos-Silva S, Ferreira N, Rivero-Juarez A, Gonçalves G, Nascimento MS. Hepatitis E Virus in Individuals Undergoing Heparin Therapy: An Observational Serological and Molecular Study. CURRENT DRUG SAFETY. 2024. 377-381. DOI: 10.2174/0115748863272272231122114732. IF: 1,1      Q4  D

Castro-Scholten S, Vasinioti VI, Caballero-Gómez J, García-Bocanegra I, Pellegrini F, Salvaggiulo A, Odigie AE, Diakoudi G, Camero M, Decaro N, Martella V, Lanave G. Identification and characterization of a novel circovirus in Iberian lynx in Spain. RESEARCH IN VETERINARY SCIENCE. 2024. DOI: 10.1016/j.rvsc.2024.105336. IF: 2,2      Q1  D2

Montes ML, Busca C, Espinosa N, Bernardino JI, Ibarra-Ugarte S, Martin-Carbonero L, Moreno C, Macias J, Rivero A, Cervero-Jimenez M, Gonzalez-Garcia J. Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile. OPEN FORUM INFECTIOUS DISEASES. 2024. DOI: 10.1093/ofid/ofae112. IF: 3,8      Q2  D3

Jarrín I, Rava M, Raposo JD, Rivero A, Guerrero JD, De Lagarde M, Sanz JM, Navarro G, Dalmau D, Blanco JR, Koerting A, Castell JG, Del Amo J. Life expectancy of people with HIV on antiretroviral therapy in Spain. AIDS. 2024. 387-395. DOI: 10.1097/QAD.0000000000003772. IF: 3,4      Q2  D4

Corma-Gómez A, Cabello A, Orviz E, Morante-Ruiz M, Ayerdi O, Al-Hayani A, Muñoz-Gómez A, De Los Santos I, Gómez-Ayerbe C, Rodrigo D, Riestra SDR, Reus-Bañuls S, Silva-Klug A, Galindo MJ, Santos M, Serrano-Fuentes M, Faro-Míguez N, Pérez-Camacho I, Corona-Mata D, Morano L, López-Ruz MA, Montero M, Anaya-Baz B, Merino D, Castillo-Navarro A, Pineda JA, Macías J. Long or complicated mpox in patients with uncontrolled HIV infection. JOURNAL OF MEDICAL VIROLOGY. 2024. DOI: 10.1002/jmv.29511. IF: 6,8      Q1  D1

Sánchez-Sánchez M, Caballero-Gómez J, Muñoz-Hernández C, Moraga-Fernández A, Fernández-Verón I, Contreras M, Baz-Flores S, del Rey T, Crespo E, Montoya-Oliver I, Salcedo J, García-Bocanegra I, de Mera IGF. Monitoring of Coxiella burnetii in the Iberian lynx (Lynx pardinus). PREVENTIVE VETERINARY MEDICINE. 2024. DOI: 10.1016/j.prevetmed.2024.106330. IF: 2,2      Q1  D2

Mega J, Moreira R, Moreira G, Silva-Loureiro A, da Silva PG, Istrate C, Santos-Silva S, Rivero-Juarez A, Carmena D, Mesquita JR. Multicentric Study on Enteric Protists Occurrence in Zoological Parks in Portugal. PATHOGENS. 2024. DOI: 10.3390/pathogens13100874. IF: 3,3      Q2  D5

Castro-Scholten S, Caballero-Gómez J, Martínez R, Nadales-Martín BJ, Cano-Terriza D, Jiménez-Martín D, Remesar S, Jiménez-Ruiz S, Gómez-Guillamón F, García-Bocanegra I. Occurrence of Coxiella burnetii in wild lagomorphs and their ticks in Spanish Mediterranean ecosystems. ZOONOSES AND PUBLIC HEALTH. 2024. 549-559. DOI: 10.1111/zph.13155. IF: 2,4      Q1  D2

Yeh-Gorocica A, Torres-Castro M, Carrillo-Chan C, Suarez-Galaz A, Suarez-Galaz M, Moguel-Chin W, Panti-May A, Lugo-Caballero C, Puerta-Guardo H, Chable-Santos J, Manrique-Saide P, Ayora-Talavera G, Selem-Salas C, Frias-Casas M, Rivero-Juarez A. Prevalence of Flavivirus and Alphavirus in bats captured in the state of Yucatan, southeastern Mexico. ONE HEALTH. 2024. DOI: 10.1016/j.onehlt.2024.100876. IF: 4,1      Q1  D2

Jiménez-Martín D, Caballero-Gómez J, Cano-Terriza D, Jiménez-Ruiz S, Paniagua J, Prieto-Yerro P, Castro-Scholten S, García-Bocanegra I. Seroepidemiology of Coxiella burnetii in Domestic and Wild Ruminant Species in Southern Spain. ANIMALS. 2024. DOI: 10.3390/ani14213072. IF: 2,7      Q1  D1

Fernandez-Bastit L, Cano-Terriza D, Caballero-Gomez J, Beato-Benitez A, Fernandez A, Garcia-Parraga D, Domingo M, Sierra C, Canales R, Borragan S, de la Riva-fraga M, Molina-Lopez R, Cabezon O, Puig-Ribas M, Espunyes J, Vazquez-Calero DB, Vergara-Alert J, Garcia-Bocanegra I, Segales J. Survey of severe acute respiratory syndrome coronavirus 2 in captive and free-ranging wildlife from Spain. VETERINARY RESEARCH. 2024. DOI: 10.1186/s13567-024-01348-0. IF: 3,7      Q1  D1

Gasca-Capote C, Lian XD, Gao C, Roseto IC, Jiménez-Léon MR, Gladkov G, Camacho-Sojo MI, Perez-Gomez A, Gallego I, Lopez-Cortes LE, Bachiller S, Vitalle J, Benhnia MRE, Ostos FJ, Collado-Romacho AR, Santos J, Palacios R, Gomez-Ayerbe C, Munoz-Medina L, Ruiz-Sancho A, Frias M, Rivero-Juarez A, Roca-Oporto C, Hidalgo-Tenorio C, Rull A, Olalla J, Lopez-Ruz MA, Vidal F, Vilades C, Mastrangelo A, Cavassini M, Espinosa N, Perreau M, Peraire J, Rivero A, López-Cortes LF, Lichterfeld M, Yu XG, Ruiz-Mateos E. The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers. JOURNAL OF CLINICAL INVESTIGATION. 2024. DOI: 10.1172/JCI174215. IF: 13,3      Q1  D1

Garcia-Sanchez P, Romero-Trancón D, Falces-Romero I, Carrera PN, Ruiz-Carrascoso G, Carmena D, Jiménez MC, Rivero-Juárez A, Moya L, Rodón J, Esperón F, Pérez-Hernando B, Sánchez-León R, Hurtado-Gallego J, Alcolea S, Sainz T, Calvo C, Méndez-Echevarría A. Zoonosis screening in Spanish immunocompromised children and their pets. FRONTIERS IN VETERINARY SCIENCE. 2024. DOI: 10.3389/fvets.2024.1425870. IF: 2,6      Q1  D2

Avalos G, Caballero-Gómez J, Matas-Méndez P, Castro-Scholten S, Jiménez-Martín D, Köster PC, Santín M, Bailo B, Cano-Terriza D, González-Barrio D, Mateo M, García-Bocanegra I, Dashti A, Nájera F, Carmena D. Detection and genotyping of zoonotic microsporidia in the endangered Iberian lynx (Lynx pardinus). MEDICAL MYCOLOGY. 2024. DOI: 10.1093/mmy/myae027. IF: 2,7      Q2  D5

Matas-Méndez P, Avalos G, Caballero-Gómez J, Dashti A, Castro-Scholten S, Jiménez-Martín D, González-Barrio D, Muñoz-de-Mier GJ, Bailo B, Cano-Terriza D, Mateo M, Nájera F, Xiao LH, Köster PC, García-Bocanegra I, Carmena D. Detection and Molecular Diversity of Cryptosporidium spp. and Giardia duodenalis in the Endangered Iberian Lynx (Lynx pardinus), Spain. ANIMALS. 2024. DOI: 10.3390/ani14020340. IF: 2,7      Q1  D1

 

Publications in 2023

Palmier E, De Miguel R, Montejano R, Busca C, Mican R, Ramos L, Cadinanos J, Serrano L, Bernardino JI, Perez-Valero I, Valencia E, Arribas JR, Montes ML, Gonzalez-Garcia J, Martin-Carbonero L. Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study. HIV MEDICINE. 2023. 1013-1019. DOI: 10.1111/hiv.13500.         IF: 3       Q3

Podzamczer D, Imaz A, Lopez-Lirola A, Knobel H, Masiá M, Fanciulli C, Hernández C, Lagarde M, Gutierrez A, Curran A, Morano L, Montero-Alonso M, Troya J, Rigo R, Casadellà M, Navarro-Alcaraz A, Ardila F, Parera M, Bernal E, Echeverria P, Estrada V, Hidalgo-Tenorio C, Macias J, Prieto P, Portilla J, Valencia E, Vivancos MJ, Rivero A. Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens. J Antimicrob Chemother. 2023 Nov 6;78(11):2696-2701. DOI: 10.1093/jac/dkad285.          IF: 5,2       Q1 D2

Moreno S, Rivero A, Ventayol P, Falco V, Torralba M, Schroeder M, Neches V, Vallejo-Aparicio LA, Mackenzie I, Turner M, Harrison C. Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain. INFECTIOUS DISEASES AND THERAPY. 2023. 2039-2055. DOI: 10.1007/s40121-023-00840-y.         IF: 5,4       Q2 D3

Lopez-Lopez P, Frias M, Perez-Jimenez AB, Freyre-Carrillo C, Pineda JA, Aguilera A, Fuentes A, Alados JC, Reina G, Ramirez-Arellano E, Viciana I, Mesquita J, Caballero-Gomez J, Rivero-Juarez A, Rivero A. Optimization of the molecular diagnosis of the acute hepatitis E virus infection. MICROBIAL BIOTECHNOLOGY. 2023. 1325-1332. DOI: 10.1111/1751-7915.14247.         IF: 5,7       Q1 D2

Ruiz-Caceres I, Romero TH, Merino IG, Zapirain JP, Perez-Mies B, Sanchez-Conde M, Riano MA, Rubio R, Alen JF, Gonzalez AV, Anton CS, Munez E, Sanchez RS, Corona-Mata D, Ansorregui IA, Miro JM, de Obanos RBP, Ibero C, Gomez-Roman J, Farinas MC, Bello TT, de Alava E, Cisneros JM, Matias-Guiu X, Rivero A, NECROCOVID Study Grp. Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections. FRONTIERS IN MEDICINE. 2023. DOI: 10.3389/fmed.2023.1151843.         IF: 3,9       Q2 D4

Bustos-Aibar M, Aguilera CM, Alcalda-Fdez J, Ruiz-Ojeda FJ, Plaza-Diaz J, Plaza-Florido A, Tofe I, Gil-Campos M, Gacto MJ, Anguita-Ruiz A. Shared gene expression signatures between visceral adipose and skeletal muscle tissues are associated with cardiometabolic traits in children with obesity. COMPUTERS IN BIOLOGY AND MEDICINE. 2023. DOI: 10.1016/j.compbiomed.2023.107085.         IF: 7,7       Q1 D1

Lopez-Lopez P, Frias M, Perez-Jimenez AB, Freyre-Carrillo C, Pineda JA, Fuentes A, Alados JC, Ramirez-Arellano E, Viciana I, Corona-Mata D, Caballero-Gomez J, Garcia-Bocanegra I, Risalde MA, Rivero-Juarez A, Rivero A. Temporal changes in the genotypes of Paslahepevirus balayani in southern Spain and their possible link with changes in pig trade imports. ONE HEALTH. 2023. DOI: 10.1016/j.onehlt.2023.100539.         IF: 5       Q1 D3

Santos-Silva S, Lopez-Lopez P, Goncalves HMR, Rivero-Juarez A, Van der Poel WHM, Nascimento MSJ, Mesquita JR. A Systematic Review and Meta-Analysis on Hepatitis E Virus Detection in Farmed Ruminants. PATHOGENS. 2023. DOI: 10.3390/pathogens12040550.         IF: 3,7       Q2 D5

Santos-Silva S, Hemnani M, Lopez-Lopez P, Goncalves HMR, Rivero-Juarez A, van der Poel WHM, Nascimento MSJ, Mesquita JR. A Systematic Review of Hepatitis E Virus Detection in Camels. VETERINARY SCIENCES. 2023. DOI: 10.3390/vetsci10050323.         IF: 2,4       Q1 D3

Oluremi AS, Casares-Jimenez M, Opaleye OO, Caballero-Gomez J, Ogbolu DO, Lopez-Lopez P, Corona-Mata D, Rivero-Juarez A, Rivero A. Butchering activity is the main risk factor for hepatitis E virus (Paslahepevirus balayani) infection in southwestern Nigeria: a prospective cohort study. FRONTIERS IN MICROBIOLOGY. 2023. DOI: 10.3389/fmicb.2023.1247467.         IF: 5,2       Q2 D3

Barroso P, Acevedo P, Risalde MA, Garcia-Bocanegra I, Montoro V, Martinez-Padilla AB, Torres MJ, Soriguer RC, Vicente J. Co-exposure to pathogens in wild ungulates from Donana National Park, South Spain. RESEARCH IN VETERINARY SCIENCE. 2023. 14-28. DOI: 10.1016/j.rvsc.2022.12.009.         IF: 2,4       Q1 D3

Corona-Mata D, Rivero-Juarez A, Camacho A, Ruiz-Torres L, Ruiz-Caceres I, Darder BD, Caceres-Anillo D, Castro-Granados MD, Lizaur-Barbudo M, Cabrera-Gisbert MV, Redondo-Ecija J, Aparicio-Aparicio A, Manchado-Lopez L, Cobos L, Perez-Valero I, Rivero A. Efficacy of a comprehensive strategy for the detection and treatment of hepatitis C infection in a population attending addiction centers. FRONTIERS IN PUBLIC HEALTH. 2023. DOI: 10.3389/fpubh.2023.1092960.         IF: 5,2       Q1 D2

Caballero-Gomez J, Rivero-Juarez A, Cano-Terriza D, Fajardo T, Buono F, Jose-Cunilleras E, Garcia J, Alguacil E, Rivero A, Garcia-Bocanegra I. Epidemiological survey and risk factors associated with Paslahepevirus balayani in equines in Europe. ONE HEALTH. 2023. DOI: 10.1016/j.onehlt.2023.100619.         IF: 5       Q1 D3

Santos-Silva S, Moraes DFDD, Lopez-Lopez P, Rivero-Juarez A, Mesquita JR, Nascimento MSJ. Hepatitis E Virus in the Iberian Peninsula: A Systematic Review. FOOD AND ENVIRONMENTAL VIROLOGY. 2023. 193-211. DOI: 10.1007/s12560-023-09560-5.         IF: 3,4       Q2 D5

Rego L, Castro-Scholten S, Cano C, Jimenez-Martin D, Koster PC, Caballero-Gomez J, Bailo B, Dashti A, Hernandez-Castro C, Cano-Terriza D, Vioque F, Maloney JG, Santin M, Garcia-Bocanegra I, Carmena D, Gonzalez-Barrio D. Iberian wild leporidae as hosts of zoonotic enteroparasites in Mediterranean ecosystems of Southern Spain. ZOONOSES AND PUBLIC HEALTH. 2023. 223-237. DOI: 10.1111/zph.13018.         IF: 2,4       Q1 D3

Vizcarra P, Moreno A, Vivancos MJ, Garcia AM, Gonzalez RP, Gutierrez F, Mata DC, Galindo P, Calzado S, Casado JL. Improving Recognition of Fracture Risk in People with Human Immunodeficiency Virus: Performance and Model Contribution of Two Common Risk Assessment Tools. AIDS PATIENT CARE AND STDS. 2023. 11-21. DOI: 10.1089/apc.2022.0183.         IF: 4,9       Q1 D2

Frías M, Corona-Mata D, Moyano JM, Camacho-Espejo A, López-López P, Caballero-Gómez J, Ruiz-Cáceres I, Casares-Jiménez M, Pérez-Valero I, Rivero-Juárez A, Rivero A. Lack of associations of microRNAs with severe NAFLD in people living with HIV: discovery case-control study. FRONTIERS IN ENDOCRINOLOGY. 2023. DOI: 10.3389/fendo.2023.1230046.         IF: 5,2       Q1 D3

Castro-Scholten S, Caballero-Gomez J, Rivero-Juarez A, Cano-Terriza D, Gomez-Guillamon F, Jimenez-Martin D, Rivero A, Garcia-Bocanegra I. Monitoring of Hepatitis E Virus in Wild Lagomorphs in Spanish Mediterranean Ecosystems. TRANSBOUNDARY AND EMERGING DISEASES. 2023. DOI: 10.1155/2023/7947220.         IF: 4,3       Q1 D1

Gonzalvez M, Franco JJ, Barbero-Moyano J, Caballero-Gomez J, Ruano MJ, Martinez R, Cano-Terriza D, Garcia-Bocanegra I. Monitoring the epidemic of West Nile virus in equids in Spain, 2020-2021. PREVENTIVE VETERINARY MEDICINE. 2023. DOI: 10.1016/j.prevetmed.2023.105975.         IF: 2,6       Q1 D2

Dashti A, Koster PC, Bailo B, de las Matas AS, Habela MA, Rivero-Juarez A, Vicente J, Serrano E, Arnal MC, de Luco DF, Morrondo P, Armenteros JA, Balseiroj A, Cardona GA, Martinez-Carrascom C, Ortiz JA, Carpio AJ, Calero-Bernal R, Gonzalez-Barrio D, Carmena D. Occurrence and limited zoonotic potential of Cryptosporidium spp., Giardia duodenalis, and Balantioides coli infections in free-ranging and farmed wild ungulates in Spain. RESEARCH IN VETERINARY SCIENCE. 2023. 189-197. DOI: 10.1016/j.rvsc.2023.04.020.         IF: 2,4       Q1 D3

Agullo-Ros I, Jimenez-Martin D, Camacho-Sillero L, Gortazar C, Capucci L, Cano-Terriza D, Zorrilla I, Gomez-Guillamon F, Garcia-Bocanegra I, Risalde MA. Pathological changes and viral antigen distribution in tissues of Iberian hare (Lepus granatensis) naturally infected with the emerging recombinant myxoma virus (ha-MYXV). VETERINARY RECORD. 2023. DOI: 10.1002/vetr.2182.         IF: 2,2       Q2 D3

Perez-Valero I, Corona D, Martinez N, Lopez-Cavanillas M, Lluis C, Luque I. Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. 2023. 655-665. DOI: 10.1080/14787210.2023.2203914.         IF: 5,7       Q1 D3

Gonzalez-Serna A, Corma-Gomez A, Tellez F, Corona-Mata D, Rios-Villegas MJ, Merino D, Galera C, Collado-Romacho AR, de los Santos I, Cucurull J, Santos M, García-Martín S, Rivero A, Real LM, Macias J. Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023. 2591-2596. DOI: 10.1093/jac/dkad278.         IF: 5,2       Q2 D3

Santos-Silva S, Moraes DFDD, Lopez-Lopez P, Palmeira JD, Torres RT, Nascimento MS, Dashti A, Carmena D, Rivero-Juarez A, Mesquita JR. Survey of Zoonotic Diarrheagenic Protist and Hepatitis E Virus in Wild Boar (Sus scrofa) of Portugal. ANIMALS. 2023. DOI: 10.3390/ani13020256.         IF: 3       Q1 D1

Palmier E, De Miguel R, Montejano R, Busca C, Mican R, Ramos L, Cadinanos J, Serrano L, Bernardino JI, Perez-Valero I, Valencia E, Arribas JR, Montes ML, Gonzalez-Garcia J, Martin-Carbonero L. Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study. HIV MEDICINE. 2023. 1013-1019. DOI: 10.1111/hiv.13500.         IF: 3       Q3 D
 

Publications in 2022

Barroso-Arevalo S, Sanchez-Morales L, Dominguez M, Garcia-Seco T, Risalde MA, Garcia-Bocanegra I, Dominguez L, Sanchez-Vizcaino JM. RESEARCH IN VETERINARY SCIENCE. 2022. DOI: 10.1016/j.rvsc.2022.05.003

Jimenez-Ruiz S, Garcia-Bocanegra I, Acevedo P, Espunyes J, Triguero-Ocana R, Cano-Terriza D, Torres-Sanchez MJ, Vicente J, Risalde MA. TRANSBOUNDARY AND EMERGING DISEASES. 2022. DOI: 10.1111/tbed.14126

Matthews PC, Campbell C, Sandulescu O, Maticic M, Ruta SM, Rivero-Juarez A, van Welzen BJ, Tan BK, Garcia F, Gherlan GS, Cinar G, Hasanoglu I, Gmizic I, Nicolini LA, Santos L, Sargsyants N, Velikov P, Habibovic S, Fourati S, Zidovec-Lepej S, Herder V, Dudman S, Miron VD, Irving W, Sahin GO. FRONTIERS IN PHARMACOLOGY. 2022. DOI: 10.3389/fphar.2022.1062408

Cano A, Gutierrez-Gutierrez B, Machuca I, Torre-Gimenez J, Gracia-Ahufinger I, Natera AM, Perez-Nadales E, Caston JJ, Rodriguez-Bano J, Martinez-Martinez L, Torre-Cisneros J. MICROBIOLOGY SPECTRUM. 2022. DOI: 10.1128/spectrum.01970-21

Hofle U, Cabrera TC, Sanchez-Cano A, de Mera IDG, Risalde MA, Moraga-Fernandez A, Ortiz JA. TRANSBOUNDARY AND EMERGING DISEASES. 2022. DOI: 10.1111/tbed.14658

Mega J, Santos-Silva S, Loureiro A, Palmeira JD, Torres RT, Rivero-Juarez A, Carmena D, Mesquita J. PATHOGENS. 2022. DOI: 10.3390/pathogens11111242

Cabello-Ubeda A, Baeza AG, Garcia JT, Moral SD, Mena MN, Martinez AP, Mican R, Gorgolas M, Tascon GC, de Santiago AD, Morerno JS, Crestelo DR, Arenzana CB, Serna JIB, Almiron MD, Cano J, Esteban H, Perez-Valero I. OPEN FORUM INFECTIOUS DISEASES. 2022. DOI: 10.1093/ofid/ofac345

Jimenez-Ruiz S, Laguna E, Vicente J, Garcia-Bocanegra I, Martinez-Guijosa J, Cano-Terriza D, Risalde MA, Acevedo P. PORCINE HEALTH MANAGEMENT. 2022. DOI: 10.1186/s40813-021-00246-7

Casades-Marti L, Frias M, Delacour S, Ruiz-Fons F. BMC ZOOLOGY. 2022. DOI: 10.1186/s40850-022-00124-x

Podzamczer D, Mican R, Tiraboschi J, Portilla J, Domingo P, Llibre JM, Ribera E, Vivancos MJ, Morano L, Masia M, Gomez C, Fanjul F, Payeras A, Inciarte A, Estrada V, Rivero A, Castro A, Bernal E, Vinuesa D, Knobel H, Troya J, Macias J, Montero M, Sanz J, Navarro-Alcaraz A, Caicedo A, Fernandez G, Martinez E, Moreno S. OPEN FORUM INFECTIOUS DISEASES. 2022. DOI: 10.1093/ofid/ofab595

Dashti A, Rivero-Juarez A, Santin M, George NS, Koster PC, Lopez-Lopez P, Risalde MA, Garcia-Bocanegra I, Gomez-Villamandos JC, Caballero-Gomez J, Frias M, Bailo B, Ortega S, Muadica AS, Calero-Bernal R, Gonzalez-Barrio D, Rivero A, Briz V, Carmena D. TRANSBOUNDARY AND EMERGING DISEASES. 2022. DOI: 10.1111/tbed.14388

Rivero-Juarez A, Dashti A, Santin M, Koster PC, Lopez-Lopez P, Risalde MA, Garcia-Bocanegra I, Gomez-Villamandos JC, Caballero-Gomez J, Frias M, Bailo B, Ortega S, Muadica AS, Calero-Bernal R, Gonzalez-Barrio D, Rivero A, Briz V, Carmena D. TRANSBOUNDARY AND EMERGING DISEASES. 2022. DOI: 10.1111/tbed.14408

Branas F, Galindo MJ, Torralba M, Antela A, Vergas J, Ramirez M, Ryan P, Dronda F, Busca C, Machuca I, Bustinduy MJ, Cabello A, Sanchez-Conde M. PLOS ONE. 2022. DOI: 10.1371/journal.pone.0266191

Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, Macgowan A, Grier S, Chazan B, Yanovskay A, Ben Ami R, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Mauer S, Rodriguez-Bano J, de Cueto M, Oliver A, de Gopegui ER, Cano A, Machuca I, Gozalo-Marguello M, Martinez-Martinez L, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstein Y, Leibovici L, Yahav D. INFECTIOUS DISEASES AND THERAPY. 2022. DOI: 10.1007/s40121-022-00657-1

Caballero-Gomez J, Garcia-Bocanegra I, Jimenez-Martin D, Cano-Terriza D, Risalde MA, Lopez-Lopez P, Jimenez-Ruiz S, Rivero A, Rivero-Juarez A. ZOONOSES AND PUBLIC HEALTH. 2022. DOI: 10.1111/zph.12935

Fanciulli C, Berenguer J, Busca C, Vivancos MJ, Tellez MJ, Dominguez L, Domingo P, Navarro J, Santos J, Iribarren JA, Morano L, Artero A, Moreno J, Rivero-Roman A, Santos I, Giner L, Arminanzas C, Montero M, Manzardo C, Cifuentes C, Garcia C, Galindo MJ, Ferrero OL, Sanz J, de la Fuente B, Rodriguez C, Gaspar G, Perez L, Losa JE, Force L, Veloso S, Martinez-Alfaro E, Jarrin I, De Miguel M, Garcia JG. HIV MEDICINE. 2022. DOI: 10.1111/hiv.13229

Jimenez-Martin D, Garcia-Bocanegra I, Risalde MA, Fernandez-Molera V, Jimenez-Ruiz S, Isla J, Cano-Terriza D. PREVENTIVE VETERINARY MEDICINE. 2022. DOI: 10.1016/j.prevetmed.2022.105637

Barroso-Arevalo S, Sanchez-Morales L, Barasona JA, Rivera B, Sanchez R, Risalde MA, Agullo-Ros I, Sanchez-Vizcaino JM. VETERINARY RESEARCH COMMUNICATIONS. 2022. DOI: 10.1007/s11259-022-09908-5

Juste RA, Ferreras-Colino E, de la Fuente J, Dominguez M, Risalde MA, Dominguez L, Cabezas-Cruz A, Gortazar C. IMMUNOLOGY. 2022. DOI: 10.1111/imm.13529

Caballero-Gomez J, Rivero-Juarez A, Zorrilla I, Lopez G, Najera F, Ulrich RG, Ruiz-Rubio C, Salcedo J, Rivero A, Paniagua J, Garcia-Bocanegra I. TRANSBOUNDARY AND EMERGING DISEASES. 2022. DOI: 10.1111/tbed.14624

Gonzalez-Serna A, Macias J, Corma-Gomez A, Tellez F, Cucurull J, Real LM, Granados R, Rivero-Juarez A, Hernandez-Quero J, Merino D, Palacios R, Rios MJ, Collado A, Pineda JA. JOURNAL OF INFECTION. 2022. DOI: 10.1016/j.jinf.2022.06.005

Ferreras-Colino E, Moreno I, Arnal MC, Balseiro A, Acevedo P, Dominguez M, de Luco DF, Gortazar C, Risalde MA. PREVENTIVE VETERINARY MEDICINE. 2022. DOI: 10.1016/j.prevetmed.2022.105612

Barroso-Arevalo S, Barneto A, Ramos AM, Rivera B, Sanchez R, Sanchez-Morales L, Perez-Sancho M, Buendia A, Ferreras E, Ortiz-Menendez JC, Moreno I, Serres C, Vela C, Risalde MA, Dominguez L, Sanchez-Vizcaino JM. TRANSBOUNDARY AND EMERGING DISEASES. 2022. DOI: 10.1111/tbed.14366

Caballero-Gomez J, Terriza DC, Pujols J, Martinez-Nevado E, Carbonell MD, Guerra R, Recuero J, Soriano P, Barbero J, Garcia-Bocanegra I. TRANSBOUNDARY AND EMERGING DISEASES. 2022. DOI: 10.1111/tbed.14147

Vaz-Rodrigues R, Ferreras-Colino E, Ugarte-Ruiz M, Pesciaroli M, Thomas J, Garcia-Seco T, Sevilla IA, Perez-Sancho M, Mateo R, Dominguez L, Gortazar C, Risalde MA. VETERINARY RESEARCH. 2022. DOI: 10.1186/s13567-022-01047-8

Rivero-Juarez A, Frias M, Perez AB, Pineda JA, Reina G, Fuentes-Lopez A, Freyre-Carrillo C, Ramirez-Arellano E, Alados JC, Rivero A. JOURNAL OF HEPATOLOGY. 2022. DOI: 10.1016/j.jhep.2022.01.028

Perez-Valero I, Blanch J, Martinez E. HIV MEDICINE. 2022. DOI: 10.1111/hiv.13296

Alvarez H, Rava M, Martinez C, Portilla J, Peraire J, Rivero A, Cervero M, Marino A, Poveda E, Llibre JM. HIV MEDICINE. 2022. DOI: 10.1111/hiv.13265

Diaz-Cao JM, Adaszek L, Dziegiel B, Paniagua J, Caballero-Gomez J, Winiarczyk S, Winiarczyk D, Cano-Terriza D, Garcia-Bocanegra I. TRANSBOUNDARY AND EMERGING DISEASES. 2022. DOI: 10.1111/tbed.14065

Moraes DFDD, Lopez-Lopez P, Palmeira JD, Torres RT, Rivero-Juarez A, Dutra V, Nascimento MSJ, Mesquita JR. TRANSBOUNDARY AND EMERGING DISEASES. 2022. DOI: 10.1111/tbed.14427

Caballero-Gomez J, Rivero-Juarez A, Jurado-Tarifa E, Jimenez-Martin D, Jimenez-Ruiz E, Castro-Scholten S, Ulrich RG, Lopez-Lopez P, Rivero A, Garcia-Bocanegra I. TRANSBOUNDARY AND EMERGING DISEASES. 2022. DOI: 10.1111/tbed.14437

Lopez-Lopez P, Frias M, Camacho A, Machuca I, Caballero-Gomez J, Risalde MA, Garcia-Bocanegra I, Perez-Valero I, Gomez-Villamandos JC, Rivero-Juarez A, Rivero A. TRANSBOUNDARY AND EMERGING DISEASES. 2022. DOI: 10.1111/tbed.14486

Corma-Gomez A, Fernandez-Fuertes M, Garcia E, Fuentes-Lopez A, Gomez-Ayerbe C, Rivero-Juarez A, Dominguez C, Santos M, Vinuela L, Palacios R, Real LM, Rivero A, Macias J, Pineda JA, Garcia F. CLINICAL MICROBIOLOGY AND INFECTION. 2022. DOI: 10.1016/j.cmi.2022.05.018

Jimenez-Ruiz S, Vicente J, Risalde MA, Acevedo P, Cano-Terriza D, Gonzalez-Barrio D, Barroso P, Garcia-Bocanegra I. TRANSBOUNDARY AND EMERGING DISEASES. 2022. DOI: 10.1111/tbed.14516

Frias M, Casades-Marti L, Risalde MA, Lopez-Lopez P, Cuadrado-Matias R, Rivero-Juarez A, Rivero A, Ruiz-Fons F. FRONTIERS IN VETERINARY SCIENCE. 2022. DOI: 10.3389/fvets.2022.874030

Frias M, Cuadrado-Matias R, Jarilla-Fernandez MD, Lopez-Lopez P, Casades-Marti L, Madrigal E, Rivero A, Rivero-Juarez A, Ruiz-Fons F. TRANSBOUNDARY AND EMERGING DISEASES. 2022. DOI: 10.1111/tbed.14484

Gomez-Ayerbe C, Palacios R, Mayorga M, Navarrete MN, Ferra S, Ruiz I, Garcia C, Castano M, Merino D, Collado A, Hidalgo-Tenorio C, Delgado M, Rivero A, Santos J. INTERNATIONAL JOURNAL OF STD & AIDS. 2022. DOI: 10.1177/09564624221125356

Dashti A, Santin M, Kooster PC, Bailo B, Ortega S, Imanna E, Habela MA, Rivero-Juarez A, Vicente J, Arnal MC, de Luco DF, Morrondo P, Armenteros JA, Balseiro A, Cardona GA, Martinez-Carrasco C, Ortiz JA, Calero-Bernal R, Carmena D, Gonzalez-Barrio D. MEDICAL MYCOLOGY. 2022. DOI: 10.1093/mmy/myac070

Publications in 2021

Frias M, Moyano JM, Rivero-Juarez A, Luna JM, Camacho A, Fardoun HM, Machuca I, Al-Twijri M, Rivero A, Ventura S. Classification Accuracy of Hepatitis C Virus Infection Outcome: Data Mining Approach. JOURNAL OF MEDICAL INTERNET RESEARCH. 202  23(2):-. DOI: 10.2196/18766.                   

IF: 5,428         Q1     D1

 

Rivero-Juarez A, Risalde MA, Gortazar C, Lopez-Lopez P, Barasona JA, Frias M, Caballero-Gomez J, de la Fuente J, Rivero A. Detection of Hepatitis E Virus in Hyalomma lusitanicum Ticks Feeding on Wild Boars. FRONTIERS IN MICROBIOLOGY. 2021.  12():-. DOI: 10.3389/fmicb.2021.692147.                   

IF: 5,64         Q1     D3

 

Frias M, Lopez-Lopez P, Zafra I, Caballero-Gomez J, Machuca I, Camacho A, Risalde MA, Rivero-Juarez A, Rivero A. Development and Clinical Validation of a Pangenotypic PCR-Based Assay for the Detection and Quantification of Hepatitis E Virus (Orthohepevirus A Genus). JOURNAL OF CLINICAL MICROBIOLOGY. 2021.  59(2):-. DOI: 10.1128/JCM.02075-20.                   

IF: 5,948         Q1     D2

 

Thomas J, Balseiro A, Gortazar C, Risalde MA. Diagnosis of tuberculosis in wildlife: a systematic review. VETERINARY RESEARCH. 2021.  52(1):-. DOI: 10.1186/s13567-020-00881-y.                   

IF: 3,699         Q1     D1

 

Casares-Jimenez M, Lopez-Lopez P, Caballero-Gomez J, Frias M, Perez-Hernando B, Oluremi AS, Risalde MA, Ruiz-Caceres I, Opaleye OO, Garcia-Bocanegra I, Rivero-Juarez A, Rivero A. Global molecular diversity of Hepatitis E virus in wild boar and domestic pig. ONE HEALTH. 2021.  13():-. DOI: 10.1016/j.onehlt.2021.100304.                   

IF: 3,8         Q2     D3

 

Risalde MA, Molina AM, Lora AJ, Ayala N, Gomez-Villamandos JC, Moyano MR. Immunohistochemical expression of aromatase cyp19a1a and cyp19a1b in the ovary and brain of zebrafish (Danio rerio) exposed to different concentrations of bisphenol A. AQUATIC TOXICOLOGY. 2021.  237():-. DOI: 10.1016/j.aquatox.2021.10587                   

IF: 4,964         Q1

 

Rivero-Juarez A, Lopez-Lopez P, Pineda JA, Alados JC, Fuentes-Lopez A, Ramirez-Arellano E, Freyre C, Perez AB, Frias M, Rivero A. Limited Value of Single Sampling for IgM Antibody Determination as a Diagnostic Approach for Acute Hepatitis E Virus Infection. MICROBIOLOGY SPECTRUM. 2021.  9(1):-. DOI: 10.1128/Spectrum.00382-21.                   

IF: 7,171         Q1     D2

 

Caballero-Gomez J, Garcia-Bocanegra I, Navarro N, Guerra R, Martinez-Nevado E, Soriano P, Cano-Terriza D. Zoo animals as sentinels for Schmallenberg virus monitoring in Spain. VETERINARY MICROBIOLOGY. 2021.  252():-. DOI: 10.1016/j.vetmic.2020.108927.                   

IF: 3,293         Q1     D1

Barroso P, Risalde MA, Garcia-Bocanegra I, Acevedo P, Barasona JA, Caballero-Gomez J, Jimenez-Ruiz S, Rivero-Juarez A, Montoro V, Vicente J. Long-Term Determinants of the Seroprevalence of the Hepatitis E Virus in Wild Boar (Sus scrofa). ANIMALS. 202  11(6):-. DOI: 10.3390/ani11061805.                   

IF: 2,752         Q1     D2

 

Corma-Gomez A, Macias J, Rivero A, Rivero-Juarez A, de los Santos I, Reus-Banuls S, Morano L, Merino D, Palacios R, Galera C, Fernandez-Fuertes M, Gonzalez-Serna A, de Rojas I, Ruiz A, Saez ME, Real LM, Pineda JA. A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure. DIAGNOSTICS. 2021. 11(8):-. DOI: 10.3390/diagnostics11081501.                   

IF: 3,706         Q2     D3

 

Gomez-Ayerbe C, Palacios R, Rios MJ, Tellez F, Sayago C, Martin-Aspas A, Camacho A, Munoz L, Santos J. Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic? INTERNATIONAL JOURNAL OF STD & AIDS. 2021.  32(13):1257-1260. DOI: 10.1177/09564624211033756.                   

IF: 1,359         Q4

 

Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, MacGowan A, Grier S, Gibbs J, Chazan B, Yanovskay A, Ben Ami R, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Mauer S, Rodriguez-Bano J, Morales I, Oliver A, de Gopegui ER, Cano A, Machuca I, Gozalo-Marguello M, Martinez LM, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstein Y, Leibovici L, Yahav D. Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021.  76(8):2172-2181. DOI: 10.1093/jac/dkab13 IF: 5,79         Q1     D2

 

Modiyinji AF, Rivero-Juarez A, Lopez-Lopez P, Atsama MA, Monamele CG, Nola M, Rivero A, Njouom R. First molecular characterization of the hepatitis E virus in humans in Cameroon: Confirmation of the HEV outbreak in Touboro, North-Cameroon. JOURNAL OF MEDICAL VIROLOGY. 2021.  93(6):4018-4022. DOI: 10.1002/jmv.26277. IF: 2,327         Q4

 

Corma-Gomez A, Macias J, Lacalle-Remigio JR, Tellez F, Morano L, Rivero A, Serrano M, Rios MJ, Vera-Mendez FJ, Alados JC, Real LM, Palacios R, De los Santos I, Imatz A, Pineda JA. Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower Risk of Hepatocellular Carcinoma After Sustained Virological Response to Direct-acting Antivirals in Hepatitis C Infected Patients With Advanced Fibrosis. CLINICAL INFECTIOUS DISEASES. 2021.  73(7):E2109-E211 DOI: 10.1093/cid/ciaa1111.

IF: 9,079         Q1     D1

 

Gonzalez-Serna A, Macias J, Palacios R, Gomez-Ayerbe C, Tellez F, Rivero-Juarez A, Fernandez M, Santos J, Real LM, Gonzalez-Domenech CM, Gomez-Mateos J, Pineda JA. Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain. HIV MEDICINE. 2021.  22(5):379-386. DOI: 10.1111/hiv.13039.

IF: 3,18         Q3

 

Nimgaonkar I, Archer NF, Becher I, Shahrad M, LeDesma RA, Mateus A, Caballero-Gomez J, Berneshawi AR, Ding Q, Douam F, Gaska JM, Savitski MM, Kim H, Ploss A. Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90. ANTIVIRAL RESEARCH. 2021.  185():-. DOI: 10.1016/j.antiviral.2020.104997. IF: 5,97         Q1     D2

 

Gonzalez-Serna A, Corma-Gomez A, Tellez F, Garcia-Martin S, Rivero-Juarez A, Frias M, Vera-Mendez FJ, De los Santos I, Merino D, Morano L, Imaz A, Galera C, Serrano M, Macias J, Pineda JA. Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021.  76(9):2375-237 DOI: 10.1093/jac/dkab157.                   

IF: 5,79         Q1     D2

 

Corma-Gomez A, Macias J, Morano L, Rivero A, Tellez F, Rios MJ, Santos M, Serrano M, Palacios R, Merino D, Real LM, De Los Santos I, Vera-Mendez FJ, Galindo MJ, Pineda JA. Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response. CLINICAL INFECTIOUS DISEASES. 2021.  72(5):E96-E102. DOI: 1093/cid/ciaa1726.                   

IF: 9,079         Q1     D1

 

Barroso P, Risalde MA, Garcia-Bocanegra I, Acevedo P, Barasona JA, Palencia P, Carro F, Jimenez-Ruiz S, Pujols J, Montoro V, Vicente J. Long-term determinants of the seroprevalence of the bluetongue virus in deer species in southern Spain. RESEARCH IN VETERINARY SCIENCE. 2021.  139():102-1 DOI: 10.1016/j.rvsc.2021.07.001.

IF: 2,534         Q1     D3

 

Garcia-Bocanegra I, Camacho-Sillero L, Caballero-Gomez J, Aguero M, Gomez-Guillamon F, Ruiz-Casas JM, Diaz-Cao JM, Garcia E, Ruano MJ, de la Haza R. Monitoring of emerging myxoma virus epidemics in Iberian hares (Lepus granatensis) in Spain, 2018-2020. TRANSBOUNDARY AND EMERGING DISEASES. 2021.  68(3):1275-1282. DOI: 10.1111/tbed.13781.                   

IF: 5,005         Q1     D1

 

Escribano-Romero E, de Oya NJ, Camacho MC, Blazquez AB, Martin-Acebes MA, Risalde MA, Muriel L, Saiz JC, Hofle U. Previous Usutu Virus Exposure Partially Protects Magpies (Pica pica) against West Nile Virus Disease But Does Not Prevent Horizontal Transmission. VIRUSES-BASEL. 2021.  13(7):-. DOI: 10.3390/v13071409.                   

IF: 5,048         Q2     D3

 

Antela A, Rivero A, Llibre JM, Moreno S. Redefining therapeutic success in HIV patients: an expert view. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021.  76(10):2501-2518. DOI: 10.1093/jac/dkab168.                   

IF: 5,79         Q1     D2

 

Gomez-Guillamon F, Caballero-Gomez J, Aguero M, Camacho-Sillero L, Risalde MA, Zorrilla I, Villalba R, Rivero-Juarez A, Garcia-Bocanegra I. Re-emergence of bluetongue virus serotype 4 in Iberian ibex (Capra pyrenaica) and sympatric livestock in Spain, 2018-2019. TRANSBOUNDARY AND EMERGING DISEASES. 2021.  68(2):458-466. DOI: 10.1111/tbed.13696.                    

IF: 5,005         Q1     D1

 

Castro-Scholten S, Cano-Terriza D, Jimenez-Ruiz S, Almeria S, Risalde MA, Vicente J, Acevedo P, Arnal MC, Balseiro A, Gomez-Guillamon F, Escribano F, Puig-Ribas M, Dubey JP, Garcia-Bocanegra I. Seroepidemiology of Toxoplasma gondii in wild ruminants in Spain. ZOONOSES AND PUBLIC HEALTH. 2021.  68(8):884-895. DOI: 10.1111/zph.12878.                   

IF: 2,702         Q1     D2

Publications in 2020

Caballero-Gomez J, Garcia Bocanegra I, Gomez-Guillamon F, Camacho-Sillero L, Zorrilla I, Lopez-Lopez P, Cano-Terriza D, Jimenez-Ruiz S, Frias M, Rivero-Juarez A. Absence of Hepatitis E virus circulation in wild rabbits (Oryctolagus cuniculus) and Iberian hares (Lepus granatensis) in Mediterranean ecosystems in Spain. TRANSBOUNDARY AND EMERGING DISEASES. 2020. 67 (4):1422-1427 DOI: 10.1111/tbed.13478 
IF: 4,188 Q: 1 D: 1

Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, Macgowan A, Grier S, Gibbs J, Chazan B, Yanovskay A, Ben Ami R, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl . Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study. CLINICAL INFECTIOUS DISEASES. 2020. 70 (11):2270-2280 DOI: 10.1093/cid/ciz668 
IF: 8,313 Q: 1 D: 1

Castan JJ, Gallo M, Garcia M, Cano A, Escribano A, Machuca I, Gracia-Aufinger I, Guzman-Puche J, Perez-Nadales E, Recio M, Munoz M, Martinez-Martinez L, Torre-Cisneros J. Ceftazidime-avibactam in the treatment of infections caused by KPC-producing Klebsiella pneumoniae: factors associated with clinical efficacy in a single-center cohort. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2020. 56 (3):- DOI: 10.1016/j.ijantimicag.2020.106075 
IF: 4,621 Q: 1

Diez-Quijada L, Medrano-Padial C, Llana-Ruiz-Cabello M, Catunescu GM, Moyano R, Risalde MA, Camean AM, Jos A. Cylindrospermopsin-Microcystin-LR Combinations May Induce Genotoxic and Histopathological Damage in Rats. TOXINS. 2020. 12 (6):- DOI: 10.3390/toxins12060348 
IF: 3,531 Q: 1

Balseiro A, Thomas J, Gortazar C, Risalde MA. Development and Challenges in Animal Tuberculosis Vaccination. PATHOGENS. 2020. 9 (6):- DOI: 10.3390/pathogens9060472 
IF: 3,018 Q: 2

Barasona JA, Risalde MA, Ortiz JA, Gonzalez-Barrio D, Che-Amat A, Perez-Sancho M, Vargas-Castillo L, Xeidakis A, Jurado-Tarifa E, Gortazar C. Disease-mediated piglet mortality prevents wild boar population growth in fenced overabundant settings. EUROPEAN JOURNAL OF WILDLIFE RESEARCH. 2020. 66 (2):- DOI: 10.1007/s10344-020-1363-6 
IF: 1,381 Q: 2

Alejos B, Suarez-Garcia I, Rava M, Bautista-Hernandez A, Gutierrez F, Dalmau D, Sagastagoitia I, Rivero A, Moreno S, Jarrin I. Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2020. 75 (10):3004-3014 DOI: 10.1093/jac/dkaa246 
IF: 5,439 Q: 1 D: 1

Dashti A, Rivero-Juarez A, Santin M, Lopez-Lopez P, Caballero-Gomez J, Frias-Casas M, Koster PC, Bailo B, Calero-Bernal R, Briz V, Carmena D. Enterocytozoon bieneusi (Microsporidia): Identification of novel genotypes and evidence of transmission between sympatric wild boars (Sus scrofa ferus) and Iberian pigs (Sus scrofa domesticus) in Southern Spain. TRANSBOUNDARY AND EMERGING DISEASES. 2020. 67 (6):2869-2880 DOI: 10.1111/tbed.13658 
IF: 4,188 Q: 1

Risalde MA, Rivero-Juarez A, Frias M, Olivas I, Lopez-Lopez P, Garcia-Bocanegra I, Brieva T, Caballero-Gomez J, Camacho A, Fernandez-Molera V, Gomez-Villamandos JC, Rivero A. Evaluation of a non-invasive screening approach to determine hepatitis E virus status of pig farms. VETERINARY RECORD. 2020. 187 (7):272- DOI: 10.1136/vr.105840 
IF: 2,442 Q: 1 D: 1

Diaz-Cao JM, Lorca-Oro C, Pujols J, Cano-Terriza D, Risalde MD, Jimenez-Ruiz S, Caballero-Gomez J, Garcia-Bocanegra I. Evaluation of two enzyme-linked immunosorbent assays for diagnosis of bluetongue virus in wild ruminants. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES. 2020. 70 ():- DOI: 10.1016/j.cimid.2020.101461 
IF: 1,573 Q: 2

Caballero-Gomez J, Cano-Terriza D, Lecollinet S, Carbonell MD, Martinez-Valverde R, Martinez-Nevado E, Garcia-Parraga D, Lowenski S, Garcia-Bocanegra I. Evidence of exposure to zoonotic flaviviruses in zoo mammals in Spain and their potential role as sentinel species. VETERINARY MICROBIOLOGY. 2020. 247 ():- DOI: 10.1016/j.vetmic.2020.108763 I
F: 3,03 Q: 1 D: 1

Rivero-Juarez A, Aguilera A, Avellon A, Garcia-Deltoro M, Garcia F, Gortazar C, Granados R, Macias J, Merchante N, Oteo JA, Perez-Gracia MT, Pineda JA, Rivero A, Rodriguez-Lazaro D, Tellez F, Morano-Amado LE. Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2020. 38 (1):28-32 DOI: 10.1016/j.eimc.2018.06.014 
IF: 1,654 Q: 4

Cano-Terriza D, Almeria S, Caballero-Gomez J, Jimenez-Martin D, Castro-Scholten S, Dubey JP, Garcia-Bocanegra I. Exposure to Toxoplasma gondii in zoo animals in Spain. PREVENTIVE VETERINARY MEDICINE. 2020. 176 ():- DOI: 10.1016/j.prevetmed.2020.104930 
IF: 2,304 Q: 1

Merchante N, Rodriguez-Fernandez M, Figueruela B, Rodriguez-Arrondo F, Revollo B, Ibarra S, Tellez F, Merino E, Montero-Alonso M, Galindo MJ, Rivero-Juarez A, de Los Santos I, Delgado-Fernandez M, Garcia-Deltoro M, Vera-Mendez FJ, Garcia MA, Aguirrebengoa. Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients. AIDS. 2020. 34 (10):1497-1507 DOI: 10.1097/QAD.0000000000002578 
IF: 4,511 Q: 1

Rivera-Espinar F, Machuca I, Tejero R, Rodriguez J, Mula A, Marfil E, Cano A, Gutierrez-Gutierrez B, Rodriguez M, Pozo JC, De la Fuente C, Rodriguez-Bano J, Martinez-Martinez L, Leon R, Torre-Cisneros J. Impact of KPC Production and High-Level Meropenem Resistance on All-Cause Mortality of Ventilator-Associated Pneumonia in Association with Klebsiella pneumoniae. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2020. 64 (6):- DOI: 10.1128/AAC.02164-19 
IF: 4,904 Q: 1

Milanes-Guisado Y, Gutierrez-Valencia A, Munoz-Pichardo JM, Rivero A, Trujillo-Rodriguez M, Ruiz-Mateos E, Espinosa N, Roca-Oporto C, Viciana P, Lopez-Cortes LF. Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2020. 75 (1):200-207 DOI: 10.1093/jac/dkz421 
IF: 5,439 Q: 1 D: 1

Mendoza-Lopez C, Lopez-Lopez P, Atienza-Ayala S, Rivero-Juarez A, Benito R. Parsonage-Turner syndrome associated with hepatitis E infection in immunocompetent patients. VIRUS RESEARCH. 2020. 290 ():- DOI: 10.1016/j.virusres.2020.198165 
IF: 2,934 Q: 2

Rivero-Juarez A, Dashti A, Lopez-Lopez P, Muadica AS, Risalde MD, Koster PC, Machuca I, Bailo B, de Mingo MH, Dacal E, Garcia-Bocanegra I, Saugar JM, Calero-Bernal R, Gonzalez-Barrio D, Rivero A, Briz V, Carmena D. Protist enteroparasites in wild boar (Sus scrofa ferus) and black Iberian pig (Sus scrofa domesticus) in southern Spain: a protective effect on hepatitis E acquisition?. PARASITES & VECTORS. 2020. 13 (1):- DOI: 10.1186/s13071-020-04152-9 
IF: 2,824 Q: 1

Caballero-Gomez J, Bocanegra IG, Rivero-Juarez A. Response to the Letter to the Editor concerning 'Absence of hepatitis E virus circulation in wild rabbits (Oryctolagus cuniculus) and Iberian hares (Lepus granatensis) in Mediterranean ecosystems in Spain' by Caballero-Gomez et al. (Transbound Emerg Dis; . TRANSBOUNDARY AND EMERGING DISEASES. 2020. 67 (5):1758-1760 DOI: 10.1111/tbed.13700 
IF: 4,188 Q: 1

Rivero-Juarez A, Vallejo N, Lopez-Lopez P, Diaz-Mareque AI, Frias M, Vallejo A, Caballero-Gomez J, Rodriguez-Velasco M, Molina E, Aguilera A. Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients. MICROORGANISMS. 2020. 8 (1):- DOI: 10.3390/microorganisms8010051 
IF: 4,152 Q: 2

Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, MacGowan A, Grier S, Chazan B, Yanovskay A, Ben Ami R, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Maurer. Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2020. 55 (2):- DOI: 10.1016/j.ijantimicag.2019.11.004 
IF: 4,621 Q: 1

Cano-Terriza D, Jimenez-Martin D, Jimenez-Ruiz S, Paniagua J, Caballero-Gomez J, Guerra R, Franco JJ, Garcia-Bocanegra I. Serosurvey of Peste des Petits Ruminants in southern Spain. TRANSBOUNDARY AND EMERGING DISEASES. 2020. 67 (6):3033-3037 DOI: 10.1111/tbed.13602 
IF: 4,188 Q: 1 D: 1

Rivero-Juarez A, Guijo-Rubio D, Tellez F, Palacios R, Merino D, Macias J, Fernandez JC, Gutierrez PA, Rivero A, Hervas-Martinez C. Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals. PLOS ONE. 2020. 15 (1):- DOI: 10.1371/journal.pone.0227188 
IF: 2,74 Q: 2

Skaathun B, Borquez A, Rivero-Juarez A, Mehta SR, Tellez F, Castano-Carracedo M, Merino D, Palacios R, Macias J, Rivero A, Martin NK. What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis. BMC INFECTIOUS DISEASES. 2020. 20 (1):- DOI: 10.1186/s12879-020-05285-z 
IF: 2,688 Q: 3

Martinez-Padilla A, Caballero-Gomez J, Magnet A, Gomez-Guillamon F, Izquierdo F, Camacho-Sillero L, Jimenez-Ruiz S, del Aguila C, Garcia-Bocanegra I. Zoonotic Microsporidia in Wild Lagomorphs in Southern Spain. ANIMALS. 2020. 10 (12):- DOI: 10.3390/ani10122218 
IF: 2,323 Q: 1 D: 1

Rivero-Juarez, A ; Frias, M ; Lopez-Lopez, P ; Berenguer, J ; Garcia, F; Macias, J ; Alcaraz, B ; Castro-Iglesias, A ; Caballero-Gomez, J; Rivero, A . Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain. FRONTIERS IN MICROBIOLOGY. 2020. 11 ():- DOI: 10.3389/fmicb.2020.564486 
IF: 4,236 Q: 1

Risalde, MA ; Romero-Palomo, F ; Lecchi, C; Ceciliani, F; Bazzocchi, C ; Comazzi, S ; Besozzi, M ; Gomez-Villamandos, JC; Luzzago, C. BVDV permissiveness and lack of expression of co-stimulatory molecules on PBMCs from calves pre-infected with BVDV. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES. 2020. 68 (101388):- DOI: 10.1016/j.cimid.2019.101388 
IF: 1,573 Q: 2

Merchante, N ; Palumbo, CS; Mazzola, G ; Pineda, JA; Tellez, F; Rivero-Juarez, A  ; Rios-Villegas, MJ ; Maurice, JB ; Westbrook, RH ; Judge, R ; Guaraldi, G; Schepis, F ; Perazzo, H ; Rockstroh, J ; Boesecke, C ; Klein, MB ; Cervo, A; Ghali, P ; Wong, P ; Petta, S; De Ledinghen, V ; Macias, J ; Sebastiani, G. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease. CLINICAL INFECTIOUS DISEASES. 2020. 71 (11):2810-2817 DOI: 10.1093/cid/ciz1181 
IF: 8,313 Q: 1 D: 1

Corma-Gomez, A ; Macias, J; Tellez, F ; Freyre-Carrillo, C; Morano, L; Rivero-Juarez, A ; Rios, MJ ; Alados, JC ; Vera-Mendez, FJ ; Merchante, N ; Palacios, R ; Granados, R; Merino, D ; De Los Santos, I ; Pineda, JA . Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals. CLINICAL INFECTIOUS DISEASES. 2020. 71 (9):2354-23692 DOI: 10.1093/cid/ciz1140 
IF: 8,313 Q: 1 D: 1

Pacheco, I ; Contreras, M ; Villar, M ; Risalde, MA ; Alberdi, P ; Cabezas-Cruz, A; Gortazar, C; de la Fuente, J. Vaccination with Alpha-Gal Protects Against Mycobacterial Infection in the Zebrafish Model of Tuberculosis. VACCINES. 2020. 8 (2):- DOI: 10.3390/vaccines8020195 
IF: 4,086 Q: 2

Publications in 2019

Perez AB, Chueca N, Garcia-Deltoro M, Martinez-Sapina AM, Lara-Perez MM, Garcia-Bujalance S, Aldamiz-Echevarria T, Vera-Mendez FJ, Pineda JA, Casado M, Pascasio JM, Salmeron J, Alados-Arboledas JC, Poyato A, Tellez F, Rivero-Juarez A, Merino D, Vivancos-G; High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world. JOURNAL OF HEPATOLOGY. 2019 Nov;71(5):876-888. doi: 10.1016/j.jhep.2019.06.022. 
IF: 18,946 D: 1

Vrancken B, Cuypers L, Perez AB, Chueca N, Anton-Basantas J, de la Iglesia A, Fuentes J, Pineda JA, Tellez F, Bernal E, Rincon P, Von Wichman MA, Fuentes A, Vera F, Rivero-Juarez A, Jimenez M, Vandamme AM, Garcia F; Cross-country migration linked to people who inject drugs challenges the long-term impact of national HCV elimination programmes. JOURNAL OF HEPATOLOGY. 2019 Dec;71(6):1270-1272. doi: 10.1016/j.jhep.2019.08.010.
IF: 18,946 Q:1 D: 1 

Macias J, Morano LE, Tellez F, Granados R, Rivero-Juarez A, Palacios R, Rios MJ, Merino D, Perez-Perez M, Collado A, Figueruela B, Morano A, Freyre-Carrillo C, Martin JM, Rivero A, Garcia F, Pineda JA; Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy. JOURNAL OF HEPATOLOGY. 2019 Jul;71(1):45-51. doi: 10.1016/j.jhep.2019.02.018.
IF: 15,04 D: 1 

Jimenez-Sousa MA, Jimenez JL, Fernandez-Rodriguez A, Brochado-Kith O, Bellon JM, Gutierrez F, Diez C, Bernal-Morell E, Viciana P, Munoz-Fernandez MA, Resino S, Moreno S, del Amo J, Dalmau D, Navarro ML, Gonzalez MI, Blanco JL, Garcia F, Rubio R, Iribarren; VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naive HIV-Infected Patients. JOURNAL OF CLINICAL MEDICINE. 2019 Mar 5;8(3). pii: E311. doi: 10.3390/jcm8030311.
IF: 5,688 D: 1 

Fresco-Taboada A, Risalde MA, Gortazar C, Tapia I, Gonzalez I, Venteo A, Sanz A, Rueda P; A lateral flow assay for the rapid diagnosis of Mycobacterium bovis infection in wild boar. TRANSBOUNDARY AND EMERGING DISEASES.  2019 Sep;66(5):2175-2179. doi: 10.1111/tbed.13260.
IF: 3,554 D: 1 

Garcia-Bocanegra I, Camacho-Sillero L, Risalde MA, Dalton KP, Caballero-Gomez J, Aguero M, Zorrilla I, Gomez-Guillamon F; First outbreak of myxomatosis in Iberian hares (Lepus granatensis). TRANSBOUNDARY AND EMERGING DISEASES. 2019 Nov;66(6):2204-2208. doi: 10.1111/tbed.13289.
IF: 3,554 D: 1 

Garcia-Bocanegra I, Rivero A, Caballero-Gomez J, Lopez-Lopez P, Cano-Terriza D, Frias M, Jimenez-Ruiz S, Risalde MA, Gomez-Villamandos JC, Rivero-Juarez A; Hepatitis E virus infection in equines in Spain. TRANSBOUNDARY AND EMERGING DISEASES. 2019 Jan;66(1):66-71. doi: 10.1111/tbed.12962
IF: 3,554 D: 1 

Caballero-Gomez J, Jimenez-Ruiz S, Lopez-Lopez P, Vicente J, Risalde MA, Cano-Terriza D, Frias M, Barasona JA, Rivero A, Garcia-Bocanegra I, Rivero-Juarez A; Emergent subtype of hepatitis E virus genotype 3 in wild boar in Spain. TRANSBOUNDARY AND EMERGING DISEASES. 2019 Sep;66(5):1803-1808. doi: 10.1111/tbed.13251.
IF: 3,554 D: 1 

Caballero-Gomez J, Rivero-Juarez A, Cano-Terriza D, Risalde MA, Lopez-Lopez P, Frias M, Jimenez-Ruiz S, Rivero A, Garcia-Bocanegra I; Survey for Hepatitis E virus infection in non-human primates in zoos in Spain. TRANSBOUNDARY AND EMERGING DISEASES. 2019 Jul;66(4):1771-1775. doi: 10.1111/tbed.13196. 
IF: 3,504 D: 1 

Roy A, Tome I, Romero B, Lorente-Leal V, Infantes-Lorenzo JA, Dominguez M, Martin C, Aguilo N, Puentes E, Rodriguez E, de Juan L, Risalde MA, Gortazar C, Dominguez L, Bezos J; Evaluation of the immunogenicity and efficacy of BCG and MTBVAC vaccines using a natural transmission model of tuberculosis. VETERINARY RESEARCH. 2019 Oct 15;50(1):82. doi: 10.1186/s13567-019-0702-7.
IF: 3,117 D: 1 
  
Camacho-Sillero L, Caballero-Gomez J, Gomez-Guillamon F, Martinez-Padilla A, Aguero M, San Miguel E, Zorrilla I, Rayas E, Talavera V, Garcia-Bocanegra I; Monitoring of the novel rabbit haemorrhagic disease virus type 2 (GI.2) epidemic in European wild rabbits (Oryctolagus cuniculus) in southern Spain, 2013-2017. 237. 108361. VETERINARY MICROBIOLOGY. 2019 Oct;237:108361. doi: 10.1016/j.vetmic.2019.07.013.
IF: 2,791 D: 1 

Thomas J, Infantes-Lorenzo JA, Moreno I, Cano-Terriza D, de Juan L, Garcia-Bocanegra I, Dominguez L, Dominguez M, Gortazar C, Risalde MA; Validation of a new serological assay for the identification of Mycobacterium tuberculosis complex-specific antibodies in pigs and wild boar. PREVENTIVE VETERINARY MEDICINE. 2019 Jan 1;162:11-17. doi: 10.1016/j.prevetmed.2018.11.004.
IF: 2,302 D: 1 

Jaimes-Bernal C, Rallon N, Benito JM, Omar M, Gomez-Vidal MA, Marquez FJ, Sanchez-Arcas B, Trujillo M, Royo JL, Saulle I, Biasin M, Rivero-Juarez A, Caruz A; A Knockout IFNL4 Variant Is Associated With Protection From Sexually Transmitted HIV-1 Infection. JOURNAL OF INFECTIOUS DISEASES. 2019 Feb 15;219(5):772-776. 
IF: 5,045 Q: 1 

Corma-Gomez A, Morano L, Tellez F, Rivero-Juarez A, Real LM, Alados JC, Rios-Villegas MJ, Vera-Mendez FJ, Munoz RP, Geijo P, Macias J, Pineda JA; HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals. AIDS. 2019 Jun 1;33(7):1167-1174. doi: 10.1097/QAD.0000000000002186.
IF: 4,914 Q: 1 

Resino S, Navarrete-Munoz MA, Blanco J, Pacheco YM, Castro I, Berenguer J, Santos J, Vera-Mendez FJ, Gorgolas M, Jimenez-Sousa MAA, Benito JM, Rallon N.  (CoRIS and the HIV Biobank integrated in the Spanish AIDS Research Network Project RIS/EPICLIN 10_201; IL7RA rs6897932 Polymorphism Is Associated with Better CD4(+) T-Cell Recovery in HIV Infected Patients Starting Combination Antiretroviral Therapy. BIOMOLECULES. 2019 Jun 16;9(6). pii: E233. doi: 10.3390/biom9060233.
IF: 4,694 Q: 1 

Machuca I, Gutierrez-Gutierrez B, Rivera-Espinar F, Cano A, Gracia-Ahufinger I, Guzman-Puche J, Marfil-Perez E, Perez-Nadales E, Caston JJ, Bonomo RA, Carmeli Y, Paterson D, Pascual A, Martinez-Martinez L, Rodriguez-Bano J, Torre-Cisneros J, Salamanca E, ; External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2019 Oct;54(4):442-448. doi: 10.1016/j.ijantimicag.2019.07.017.
IF: 4,615 Q: 1 

Real LM, Fernandez-Fuertes M, Saez ME, Rivero-Juarez A, Frias M, Tellez F, Santos J, Merino D, Moreno-Grau S, Gomez-Salgado J, Gonzalez-Serna A, Corma-Gomez A, Ruiz A, Macias J, Pineda JA; A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study). LIVER INTERNATIONAL. 2019 Oct;39(10):1918-1926. doi: 10.1111/liv.14177. 
IF: 4,5 Q: 1 

Rodriguez-Gomez J, Perez-Nadales E, Gutierrez-Gutierrez B, Machuca I, Martinez-Martinez L, Rivera F, Cano A, Caston JJ, Robles JC, de la Fuente C, Rodriguez-Lopez F, Rodriguez-Bano J, Torre-Cisneros J; Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: The impact of inappropriate empirical treatment. JOURNAL OF INFECTION. 2019 Sep;79(3):245-252. doi: 10.1016/j.jinf.2019.06.014.
IF: 5,099 Q: 1 

Merchante N, Figueruela B, Rodriguez-Fernandez M, Rodriguez-Arrondo F, Revollo B, Ibarra S, Galindo MJ, Merino E, Montero M, Tellez F, Garcia-Deltoro M, Rivero-Juarez A, Delgado-Fernandez M, Rios-Villegas MJ, Aguirrebengoa K, Garcia MA, Portu J, Vera-Mend; Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients. AIDS. 2019 Feb 1;33(2):269-278. doi: 10.1097/QAD.0000000000002065.
IF: 4,499 Q: 1 

Rivero-Juarez A, Lopez-Lopez P, Frias M, Rivero A; Hepatitis E Infection in HIV-Infected Patients. FRONTIERS IN MICROBIOLOGY. 2019 Jun 26;10:1425. doi: 10.3389/fmicb.2019.01425.
IF: 4,259 Q: 1 

Lopez-Lopez P, Rivero-Juarez A, Frias M, Machuca I, Caballero-Gomez J, Olivas I, Camacho A, Risalde MD, Garcia-Bocanegra I, Rivero A; Mutations in the Progesterone Receptor (PROGINS) May Reduce the Symptoms of Acute Hepatitis E and Protect Against Infection. FRONTIERS IN MICROBIOLOGY. 2019 Nov 7;10:2617. doi: 10.3389/fmicb.2019.02617.
IF: 4,259 Q: 1 D: 2 


Neukam K, Fernandez MD, Quero JH, Rivero-Juarez A, Llaves-Flores S, Onate FJ, Gutierrez-Valencia A, Espinosa N, Viciana P, Lopez-Cortes LF; Response to Hepatitis A Virus Vaccine in HIV-Infected Patients Within a Retrospective, Multicentric Cohort: Facing Hepatitis A Outbreaks in the Clinical Practice. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2019 May 1;81(1):e1-e5. doi: 10.1097/QAI.0000000000001990.
IF: 4,116 Q:1 

Macias J, Granados R, Tellez F, Merino D, Perez M, Morano LE, Palacios R, Paniagua M, Frias M, Merchante N, Pineda JA, Merchante N, Mancebo M, Rivero A, Rivero-Juarez A, Marquez M, Ojeda G, Santos J, Romero J, de los Santos I, Omar M, Gomez-Vidal MA, Prad; Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection. JOURNAL OF VIRAL HEPATITIS. 2019 Jan;26(1):16-24. doi: 10.1111/jvh.12990.
IF: 4,016 Q: 1

Macias J, Tellez F, Rivero-Juarez A, Palacios R, Morano LE, Merino D, Collado A, Garcia-Fraile L, Omar M, Pineda JA, Merchante N, Mancebo M, Rivero A, Marquez M, Romero J, de los Santos I, Gomez-Vidal MA; Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients. JOURNAL OF VIRAL HEPATITIS. 2019 Jan;26(1):48-54. doi: 10.1111/jvh.13003.
IF: 4,016 Q: 1 

Rivero-Juarez A, Jarilla-Fernandez M, Frias M, Madrigal-Sanchez E, Lopez-Lopez P, Andujar-Troncoso G, Machuca I, Camacho A, Munoz-Valbuena P, Rivero A; Hepatitis E virus in Spanish donors and the necessity for screening. JOURNAL OF VIRAL HEPATITIS. 2019 May;26(5):603-608. doi: 10.1111/jvh.13064.
IF: 4,016 Q: 1 

Frias M, Rivero-Juarez A, Tellez F, Palacios R, Jimenez-Arranz A, Pineda JA, Merino D, Gomez-Vidal MA, Perez-Camacho I, Camacho A, Rivero A; Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR. SCIENTIFIC REPORTS. 2019 Aug 29;9(1):12507. doi: 10.1038/s41598-019-48966-9.
IF: 4,011 Q: 1 

Real LM, Macias J, Rivero-Juarez A, Tellez F, Merino D, Moreno-Grau S, Orellana A, Gomez-Salgado J, Saez ME, Frias M, Corma-Gomez A, Merchante N, Ruiz A, Caruz A, Pineda JA, Fernandez-Fuertes M, Iglesias M, Rincon P; Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection. SCIENTIFIC REPORTS. 2019 Jun 21;9(1):9054. doi: 10.1038/s41598-019-45389-4.
IF: 4,011 Q: 1 

Thomas J, Infantes-Lorenzo JA, Moreno I, Romero B, Garrido JM, Juste R, Dominguez M, Dominguez L, Gortazar C, Risalde MA; A new test to detect antibodies against Mycobacterium tuberculosis complex in red deer serum. VETERINARY JOURNAL. 2019 Feb;244:98-103. doi: 10.1016/j.tvjl.2018.12.021. 
IF: 1,919 Q: 1 
  
Cano-Terriza D, Almeria S, Caballero-Gomez J, Diaz-Cao JM, Jimenez-Ruiz S, Dubey JP, Garcia-Bocanegra I; Serological survey of Toxoplasma gondii in captive nonhuman primates in zoos in Spain. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES. 2019 Aug;65:54-57. doi: 10.1016/j.cimid.2019.04.002.
IF: 1,871 Q: 1 

Lopez-Lopez P, Frias M, Camacho A, Rivero A, Rivero-Juarez A; Human Immunodeficiency Virus Infected Patients are Not at Higher Risk for Hepatitis E Virus Infection: A Systematic Review and Meta-Analysis. MICROORGANISMS. 2019 Nov 26;7(12). pii: E618. doi: 10.3390/microorganisms7120618.
IF: 4,167 Q: 2 

Perez AB, Chueca N, Macias J, Pineda JA, Salmeron J, Rivero-Juarez A, Hidalgo-Tenorio C, Espinosa MD, Tellez F, Von-Wichmann MA, Omar M, Santos J, Hernandez-Quero J, Anton JJ, Collado A, Lozano AB, Garcia-Deltoro M, Casado M, Pascasio JM, Selfa A, Rosales; Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort. PLOS ONE. 2019 Aug 30;14(8):e0221231. doi: 10.1371/journal.pone.0221231.
IF: 3,776 Q: 2 

Rivero-Juarez A, Tellez F, Castano-Carracedo M, Merino D, Espinosa N, Santos J, Macias J, Paniagua-Garcia M, Zapata-Lopez A, Collado A, Gomez-Vidal MA, Perez-Stachowski J, Munoz-Medina L, Fernandez-Fuertes E, Rivero A; Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients. HIV MEDICINE. 2019 Jul;20(6):359-367. doi: 10.1111/hiv.12715.
IF: 3,734 Q: 2 
  
Alejos B, Suarez-Garcia I, Bisbal O, Iribarren JA, Asensi V, Gorgolas M, Muga R, Moreno S, Jarrin I. (CoRIS cohort: Jarrin, I; Dalmau, D; Navarro, ML; Gonzalez, MI; Blanco, JL; Garcia, F; Rubio, R; Iribarren, JA; Gutierrez, F; Vidal, F; Berenguer, J; Gonz; Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors. PLOS ONE. 2019 Aug 26;14(8):e0221598. doi: 10.1371/journal.pone.0221598
IF: 2,776 Q: 2 

Aguilar-Jimenez W, Zapata W, Rivero-Juarez A, Pineda JA, Laplana M, Taborda NA, Biasin M, Clerici M, Caruz A, Fibla J, Rugeles MT; Genetic associations of the vitamin D and antiviral pathways with natural resistance to HIV-1 infection are influenced by interpopulation variability. INFECTION GENETICS AND EVOLUTION. 2019 Sep;73:276-286. doi: 10.1016/j.meegid.2019.05.014.
IF: 2,611 Q: 3

Publications in 2018

Rivero-Juarez A, Aguado R, Lopez-Lopez P, Sanchez-Frias M, Frias M, Briceno J, de la Mata M, Torre-Cisneros J, Rivero A. Prevalence of hepatitis E virus infection in liver donors in Spain. CLINICAL MICROBIOLOGY AND INFECTION. 2018. 24(11)1218-1219.
IF: 6,425 Q: 1 D: 1

Rivero-Juarez A, Frias M, Lopez-Lopez P, Martinez-Peinado A, Risalde MA, Brieva T, Machuca I, Camacho A, Garcia-Bocanegra I, Gomez-Villamandos JC, Rivero A. Detection of hepatitis E virus RNA in saliva for diagnosis of acute infection. ZOONOSES AND PUBLIC HEALTH. 2018. 65 (5) 584-588.
IF: 2,164 Q: 1 D: 1

Lopez-Lopez P, Risalde MD, Frias M, Garcia-Bocanegra I, Brieva T, Caballero-Gomez J, Camacho A, Fernandez-Molera V, Machuca I, Gomez-Villamandos JC, Rivero A, Rivero-Juarez A. Risk factors associated with hepatitis E virus in pigs from different production systems. VETERINARY MICROBIOLOGY. 2018. 224 () 88-92.
IF: 2,791 Q: 1 D: 1

Rivero-Juarez A, Risalde MA, Frias M, Garcia-Bocanegra I, Lopez-Lopez P, Cano-Terriza D, Camacho A, Jimenez-Ruiz S, Gomez-Villamandos JC, Rivero A. Prevalence of hepatitis E virus infection in wild boars from Spain: a possible seasonal pattern?. BMC VETERINARY RESEARCH. 2018.14(1)5
IF: 1,792 Q: 1

Frias M, Rivero-Juarez A, Rodriguez-Cano D, Camacho A, Lopez-Lopez P, Risalde MA, Manzanares-Martin B, Brieva T, Machuca I, Rivero A. HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance. SCIENTIFIC REPORTS. 2018. 8(1) 659.
IF: 4,011 Q: 1

Rivero-Juarez A, Camacho A, Brieva T, Frias M, Lopez-Lopez P, Risalde MA, Machuca I, Caston JJ, Martinez-Peinado A, Rivero A. Differential Timing of Cholesterol Increase During Successful HCV Therapy: Impact of Type of Drug Combination. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2018. 78(4)437-440.
IF: 3,863 Q: 1

Rivero-Juarez A, Brieva T, Frias M, Rivero A. Pharmacodynamic and pharmacokinetic evaluation of the combination of daclatasvir/sofosbuvir/ribavirin in the treatment of chronic hepatitis C. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2018. 14 (9) 901-910.
IF: 3,487 Q: 2

Frias M, Lopez-Lopez P, Rivero A, Rivero-Juarez A. Role of Hepatitis E Virus Infection in Acute-on-Chronic Liver Failure. BIOMED RESEARCH INTERNATIONAL. 201()9098535.
IF: 2,197 Q: 2

Frias M, Rivero-Juarez A, Lopez-Lopez P, Rivero A. Pharmacogenetics and the treatment of HIV-/HCV-coinfected patients. PHARMACOGENOMICS. 2018. 19 (12) 979-995.
IF: 2,265 Q: 3

Rivero A, Perez-Molina JA, Blasco AJ, Arribas JR, Asensi V, Crespo M, Domingo P, Iribarren JA, Lazaro P, Lopez-Aldeguer J, Lozano F, Martinez E, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, Santos J, de la Torre J, Tuset M, Gatell JM. Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018. 36(5) 268-276.
IF: 1,685 Q: 3

Rivero A, Polo R, Aldeguer JL, Lozano F, Antela A, Arribas JR, Asensi V, Berenguer J, Blanco JR, Casado JL, Clotet B, Crespo M, Domingo P, Duenas C, Gatell JM, Gomez-Sirvent JL, Gonzalez-Garcia J, Iribarren JA, de Quiros JCLB, Cortes LFL, Losa JE, Mallolas J, Marino A, Martinez E, Miro JM, Moreno S, Palacios R, Pasquau J, Pineda JA, Podzamczer D, Portilla J, Poveda E, Pulido F, Rubio R, Santos J, Moreno JS, Sanz JS, Tellez MJ, de la Torre J, Tuset M, Molina JAP. Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2017). ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018. 36 (7) 435-445.
IF: 1,685 Q: 3

Machuca I, Vidal E, de la Torre-Cisneros J, Rivero-Roman A. Tuberculosis in immunosuppressed patients. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018. 36 (6) 366-374.
IF: 1,685 Q: 3

Esteban R, Pineda JA, Calleja JL, Casado M, Rodriguez M, Turnes J, Amado LEM, Morillas RM, Forns X, Acevedo JMP, Andrade RJ, Rivero A, Carrion JA, Lens S, Riveiro-Barciela M, McNabb B, Zhang GL, Camus G, Stamm LM, Brainard DM, Subramanian GM, Buti M. Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis. GASTROENTEROLOGY. 2018. 155(4) 1120-1127.
IF: 19,233 Q: 1 D: 1

Rodriguez-Bano J, Gutierrez-Gutierrez B, Machuca I, Pascual A. Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. CLINICAL MICROBIOLOGY REVIEWS. 2018.31(2)-.
IF: 17,750 Q: 1 D: 1

Amat T, Gutierrez-Pizarraya A, Machuca I, Gracia-Ahufinger I, Perez-Nadales E, Torre-Gimenez A, Garnacho-Montero J, Cisneros JM, Torre-Cisneros J. The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii. CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(6):630-634.
IF: 5,394 Q: 1 D: 1

Perez-Valero I, Pasquau J, Rubio R, Rivero A, Santos J, Sanz J, Marino A, Crespo M, Hernandez-Quero J, Iribarren JA, Gutierrez F, Terron A, Esteban H, Perez-Molina JA. Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018. 73(9) 2444-2451.
IF: 5,113 Q: 1 D: 1

Merchante N, Rivero-Juarez A, Tellez F, Merino D, Rios-Villegas MJ, Villalobos M, Omar M, Rincon P, Rivero A, Perez-Perez M, Raffo M, Lopez-Montesinos I, Palacios R, Gomez-Vidal MA, Macias J, Pineda JA. Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018. 73 (9) 2435-2443.
IF: 5,113 Q: 1 D: 1

Cuypers L, Perez AB, Chueca N, Aldamiz-Echevarria T, Alados JC, Martinez-Sapina AM, Merino D, Pineda JA, Tellez F, Espinosa N, Salmeron J, Rivero-Juarez A, Vivancos MJ, Hontanon V, Vandamme AM, Garcia F. Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis. PLOS ONE.  2018.13(7)-.
IF: 2,766 Q: 1

Roy A, Risalde MA, Bezos J, Casal C, Romero B, Sevilla I, Diez-Guerrier A, Rodriguez-Bertos A, Dominguez M, Garrido J, Gortazar C, Dominguez L. Response of goats to intramuscular vaccination with heat-killed Mycobacterium bovis and natural challenge. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES. 2018. 60() 28-34.
IF: 1,92 Q: 1

Merchante N, Rodriguez-Arrondo F, Revollo B, Merino E, Ibarra S, Galindo MJ, Montero M, Garcia-Deltoro M, Rivero-Juarez A, Tellez F, Delgado-Fernandez M, Rios-Villegas MJ, Garcia MA, Vera-Mendez FJ, Ojeda-Burgos G, Lopez-Ruz MA, Metola L, Omar M, Aleman-Valls MR, Aguirrebengoa K, Portu J, Raffo M, Macias J, Pineda JA. Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients. AIDS. 201 32 (11) 1423-1430.
IF: 4,914 Q: 1

Clinical Research

Active in 2025

Estudio de fase IV, multicéntrico, abierto y aleatorizado, para evaluar el impacto del cambio de tratamiento antirretroviral de terapia dual a terapia triple sobre la inflamación en pacientes con infección por VIH tipo 1 IP: ANTONIO RIVERO ROMAN

Ensayo clínico fase IV, aleatorizado, multicéntrico y doble ciego diseñado para evaluar la seguridad y la conveniencia del cambio de Dolutegravir/Lamivudina por Bictegravir/Emtricitabina/Tenofovir alafenamida en personas con VIH, buen control virológico y vulnerabilidades neuropsiquiátricas: Estudio MIND IP: IGNACIO PEREZ VALERO

Estudio de fase 3b, abierto, aleatorizado, controlado con tratamiento estándar, multicéntrico, de superioridad para evaluar la eficacia, la seguridad y la tolerabilidad de CAB AP + RPV AP inyectable en participantes virémicos que viven con VIH-1 (CROWN) IP: ANTONIO RIVERO ROMAN

Estudio multicéntrico, aleatorizado, doble ciego y controlado con placebo para evaluar la eficacia y seguridad del tratamiento con Bepirovirsen en participantes portadores crónicos del virus de la inmunodeficiencia humana y del virus de la hepatitis B, que reciben tratamiento antirretroviral IP: DIANA CORONA MATA

An Operationally Seamless Phase 2/3, Randomized, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of GS-1720 in Combination With GS-4182 Versus Biktarvy in Virologically Suppressed People With HIV-1 IP: ANTONIO RIVERO ROMAN

Evaluation of the real-life impact of switching from daily oral ART to CAB LA + RPV LA on satisfaction, treatment acceptance, and health-related quality of life IP: ANTONIO RIVERO ROMAN

Estudio exploratorio de fase 1b, multicéntrico, aleatorizado y abierto para investigar el impacto de la administración de VH3810109 intravenoso con o sin fostemsavir oral en combinación con terapia antirretroviral basada en inhibidores de la integrasa sobre el reservorio viral en adultos que viven con VIH-1 (ENTRANCE) IP: ANTONIO RIVERO ROMAN

Active in 2024

Estudio de fase IV, multicéntrico, abierto y aleatorizado, para evaluar el impacto del cambio de tratamiento antirretroviral de terapia dual a terapia triple sobre la inflamación en pacientes con infección por VIH tipo 1 IP: ANTONIO RIVERO ROMAN

ESTUDIO TRANSVERSAL DE LA COINFECCION VIH-VHC IP: ANTONIO RIVERO ROMAN

Cohorte de seguimiento propsectiva de los pacientes con hepatopía crónica VHC genotipo 1 y 3 con respuesta viral sostenida a los antivirales de acción directa libres de interferón, coinfectados y no coinfectados por el VIH. IP: ANTONIO RIVERO ROMAN

Ensayo clínico fase IV, aleatorizado, multicéntrico y doble ciego diseñado para evaluar la seguridad y la conveniencia del cambio de Dolutegravir/Lamivudina por Bictegravir/Emtricitabina/Tenofovir alafenamida en personas con VIH, buen control virológico y vulnerabilidades neuropsiquiátricas: Estudio MIND IP: IGNACIO PÉREZ VALERO

Clínica y Epidemiología del brote de infección por Monkeypox en España en el año 2022 IP: ANTONIO RIVERO ROMAN

Estudio en vida real sobre el uso de Cabotegravir/Rilpivirina de acción prolongada (CAB/RPV AP) en pacientes pretratados que viven con el VIH (PVVIH). IP: ANTONIO RIVERO ROMAN

Active in 2023

Ensayo clínico fase 4, aleatorizado, para evaluar el efecto en la recuperación inmunológica y en la reducción del reservorio viral y en la activación inmune de una terapia antirretroviral triple basada en dolutegravir más tenofovir alafenamida/emtricitabina versus una biterapia con dolutegravir más lamivudina en pacientes con infección por el VIH sin tratamiento previo.. IP: ANTONIO RIVERO ROMAN

Ensayo clínico fase IV, aleatorizado, multicéntrico y doble ciego diseñado para evaluar la seguridad y la conveniencia del cambio de Dolutegravir/Lamivudina por Bictegravir/Emtricitabina/Tenofovir alafenamida en personas con VIH, buen control virológico y vulnerabilidades neuropsiquiátricas: Estudio MIND. IP: IGNACIO PÉREZ VALERO

Ensayo clínico piloto para evaluar la eficacia, seguridad y tolerabilidad del cambio a un tratamiento con Bictegravir/FTC/TAF  (Biktarvy®) más darunavir/cobicistat en pacientes infectados por VIH-1 altamente tratados.. IP: ANTONIO RIVERO ROMAN

Estudio  fase I/II (primera vez en humanos), multicéntrico, aleatorizado, simple ciego y de escalado controlado de dosis para evaluar la reactogenicidad, la seguridad, la inmunogenicidad y la eficacia de las vacunas frente al VHB basadas en vectores virales de GSK Biologicals administradas en una pauta de primovacunación - refuerzo, con administración secuencial o conjunta de una vacuna terapéutica de proteínas adyuvada (GSK3528869A), en pacientes con hepatitis B crónica (18 a 65 años) en tratamiento con análogos de nucleótidos (AN). IP: IGNACIO PÉREZ VALERO

Estudio de fase IV, multicéntrico, abierto y aleatorizado, para evaluar el impacto del cambio de tratamiento antirretroviral de terapia dual a terapia triple sobre la inflamación en pacientes con infección por VIH tipo 1. IP: ANTONIO RIVERO ROMAN

Estudio Fase IIIb, aleatorizado, multicéntrico, abierto, de grupos paralelos, de no inferioridad que evalúa la eficacia, seguridad y tolerabilidad de cabotegravir de acción prolongada más rilpivirina de acción prolongada administrados cada 8 semanas o cada 4 semanas en adultos infectados por VIH-1 que presentan supresión virológica.. IP: ANTONIO RIVERO ROMAN

Estudio multicéntrico, aleatorizado, doble ciego, controlado por placebo en fase 3 para evaluar la eficacia de un régimen de vacuna heteróloga de Ad26.Mos4.HIV con gp140 del subtipo C y el mosaico gp140 como adyuvantes para prevenir la infección por VIH-1 entre hombres cisgénero y personas transgénero que tienen sexo con hombres cisgénero y/o personas transgénero.. IP: ANTONIO RIVERO ROMAN

Active in 2022

Estudio  fase I/II (primera vez en humanos), multicéntrico, aleatorizado, simple ciego y de escalado controlado de dosis para evaluar la reactogenicidad, la seguridad, la inmunogenicidad y la eficacia de las vacunas frente al VHB basadas en vectores viral.     PI: DR. IGNACIO PÉREZ VALERO

Estudio Fase IIIb, aleatorizado, multicéntrico, abierto, de grupos paralelos, de no inferioridad que evalúa la eficacia, seguridad y tolerabilidad de cabotegravir de acción prolongada más rilpivirina de acción prolongada administrados cada 8 semanas o cad.     PI: DR. ANTONIO RIVERO ROMAN

Ensayo clínico piloto para evaluar la eficacia,  seguridad y tolerabilidad del cambio a un tratamiento con Bictegravir/FTC/TAF  (Biktarvy®) más darunavir/cobicistat en pacientes infectados por VIH-1 altamente  tratados..     PI: DR. ANTONIO RIVERO ROMAN

Ensayo clínico fase 4, aleatorizado, para evaluar el efecto en la recuperación inmunológica y en la reducción del reservorio viral y en la activación inmune de una terapia antirretroviral triple basada en dolutegravir más tenofovir alafenamida/emtricitabi.     PI: DR. ANTONIO RIVERO ROMAN

Clínica y Epidemiología del brote de infección por Monkeypox en España en el año 2022.     PI: DR. ANTONIO RIVERO ROMAN

Estudio de fase IV, multicéntrico, abierto y aleatorizado, para evaluar el impacto del cambio de tratamiento antirretroviral de terapia dual a terapia triple sobre la inflamación en pacientes con infección por VIH tipo 1.     PI: DR. ANTONIO RIVERO ROMAN

Ensayo clínico fase IV, aleatorizado, multicéntrico y doble ciego diseñado para evaluar la seguridad y la conveniencia del cambio de Dolutegravir/Lamivudina por Bictegravir/Emtricitabina/Tenofovir alafenamida en personas con VIH, buen control virológico y.     PI: DR. IGNACIO PÉREZ VALERO

Estudio doble ciego aleatorizado en fase 3 para evaluar la seguridad y eficacia de atazanavir reforzado con GS-9350 en comparación con atazanavir reforzado con ritonavir administrado con emtricitabina/fumarato de disoproxilo de tenofovir en adultos infect.     PI: DR. ANTONIO RIVERO ROMAN

Cohorte de seguimiento propsectiva de los pacientes con hepatopía crónica VHC genotipo 1 y 3 con respuesta viral sostenida a los antivirales de acción directa libres de interferón, coinfectados y no coinfectados por el VIH..     PI: DR. ANTONIO RIVERO ROMAN

ESTUDIO TRANSVERSAL DE LA COINFECCION VIH-VHC.     PI: DR. ANTONIO RIVERO ROMAN

Estudio multicéntrico, aleatorizado, doble ciego, controlado por placebo en fase 3 para evaluar la eficacia de un régimen de vacuna heteróloga de Ad26.Mos4.HIV con gp140 del subtipo C y el mosaico gp140 como adyuvantes para prevenir la infección por VIH-1.     PI: DR. ANTONIO RIVERO ROMAN

Members

Principal Investigator
Antonio Rivero Román

Co-Investigators Principal
Antonio Rivero Juárez

Researcher
Ángela Camacho Espejo
Mario Frías Casas
Javier Caballero Gómez
Pedro López López
Ignacio Pérez Valero

Post-Doctoral Researchers
María Casares Jiménez
Diana Corona Mata
Marina Gallo Marín

Pre-Doctoral Researchers
Tomás Fajardo Alonso
Lucía Ríos Muñoz
Claudia Sofia Ferreira Tatá

 

Nursing, Technical, and Administrative Staff
María del Carmen Romero Morales
Laura Ruiz Torres
Ismael Zafra Soto